OriginClear (OCLN) 10-Q 14 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2024	Aug. 13, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Information [Line Items]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	0001419793
Entity File Number	333-147980
Entity Tax Identification Number	26-0287664
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	13575 58th Street North
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
Entity Phone Fax Numbers [Line Items]
City Area Code	(727)
Local Phone Number	440-4603
Entity Listings [Line Items]
Title of 12(b) Security	N/A
No Trading Symbol Flag	true
Security Exchange Name	NONE
Entity Common Stock, Shares Outstanding		1,585,533,032

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 32,899	$ 114,639
Current assets held-for-sale	1,961,320	2,338,798
Fair value investment in securities	36,167	36,167
Prepaid expenses	11,048
TOTAL CURRENT ASSETS	2,041,434	2,489,604
Net property and equipment	130,232	143,366
Net property and equipment held-for-sale	2,006	3,370
NET PROPERTY AND EQUIPMENT	132,238	146,736
OTHER ASSETS
Receivable on sale of asset	33,000	99,000
Non-current assets held for sale	418,000	400,000
Fair value investment-securities	3,200	3,200
Trademark	4,467	4,467
TOTAL OTHER ASSETS	458,667	506,667
TOTAL ASSETS	2,632,339	3,143,007
CURRENT LIABILITIES:
Accounts payable and other payable	818,125	647,483
Accrued expenses	1,867,045	1,774,513
Cumulative preferred stock dividends payable	613,215	523,403
Customer deposit	2,950	2,950
Secured loans payable		30,646
Loans payable, SBA	145,890	147,217
Derivative liabilities	14,336,270	7,742,759
Convertible promissory notes, net of discount of $0 and $0, respectively	597,944	2,472,944
Current liabilities held-for-sale	25,516,270	20,980,431
TOTAL CURRENT LIABILTIES	44,294,859	34,739,496
Long Term Liabilities
Convertible promissory notes, net of discount of $0 and $0, respectively	2,019,747	144,747
TOTAL LONG TERM LIABILITIES	2,019,747	144,747
TOTAL LIABILITIES	46,314,606	34,884,243
COMMITMENTS AND CONTINGENCIES (Note 13)
Convertible preferred stock	7,307,822	7,522,722
SHAREHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value, 600,000,000 shares authorized 31,500,000 and 31,5000,000 shares of Series D-1 issued and outstanding, respectively 1,000 and 1,000 shares of Series C issued and outstanding, respectively	3,150	3,150
Subscription payable for purchase of equipment	100,000	100,000
Common stock, $0.0001 par value, 16,000,000,0000 shares authorized 1,613,089,087 and 1,399,782,046 equity shares issued and outstanding, respectively	161,309	139,978
Additional paid in capital - Common stock	82,490,747	81,949,274
Noncontrolling interest	(2,593,979)	(2,239,493)
Accumulated other comprehensive loss	(132)	(132)
Accumulated deficit	(131,151,184)	(119,216,735)
TOTAL SHAREHOLDERS’ DEFICIT	(50,990,089)	(39,263,958)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	2,632,339	3,143,007
Series F Preferred Stock
CURRENT LIABILITIES:
Series Preferred Stock	50,000	60,000
Series G Preferred Stock
CURRENT LIABILITIES:
Series Preferred Stock	25,000	25,000
Series I 8% Preferred Stock
CURRENT LIABILITIES:
Series Preferred Stock	25,000	25,000
Series K 8% Preferred Stock [Member]
CURRENT LIABILITIES:
Series Preferred Stock	297,150	307,150
Series J Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	210,000	210,000
Series L Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	320,495	320,495
Series M Preferred Stock
Long Term Liabilities
Convertible preferred stock	1,007,500	1,007,500
Series O 8% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	185,000	190,000
Series P Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	30,000	30,000
Series Q 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	410,000	420,000
Series R 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	1,473,000	1,608,000
Series S 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	110,000	120,000
Series U Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	270,000	270,000
Series W 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	696,500	886,500
Series Y Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	$ 2,595,327	$ 2,460,227

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Preferred stock, shares authorized	600,000,000	600,000,000
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	160,000,000,000	160,000,000,000
Common stock, shares issued	1,613,089,087	1,399,782,046
Common stock, shares outstanding	1,613,089,087	1,399,782,046
Series F Preferred Stock
Preferred stock, shares issued	50	60
Preferred stock, shares outstanding	50	60
Preferred stock, redeemable value (in Dollars)	$ 50,000	$ 60,000
Series G Preferred Stock
Preferred stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series I 8% Preferred Stock
Preferred stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series K 8% Preferred Stock
Preferred stock, shares issued	297.15	307.15
Preferred stock, shares outstanding	297.15	307.15
Preferred stock, redeemable value (in Dollars)	$ 297,150	$ 307,150
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 210,000	$ 210,000
Convertible preferred stock, shares issued	210	210
Convertible preferred stock, shares outstanding	210	210
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 320,495	$ 320,495
Convertible preferred stock, shares issued	320,495	320,495
Convertible preferred stock, shares outstanding	320,495	320,495
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,007,500	$ 1,007,500
Convertible preferred stock, shares issued	40,300	40,300
Convertible preferred stock, shares outstanding	40,300	40,300
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 185,000	$ 190,000
Convertible preferred stock, shares issued	185	190
Convertible preferred stock, shares outstanding	185	190
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 30,000	$ 30,000
Convertible preferred stock, shares issued	30	30
Convertible preferred stock, shares outstanding	30	30
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 410,000	$ 420,000
Convertible preferred stock, shares issued	410	420
Convertible preferred stock, shares outstanding	410	420
Series R 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,473,000	$ 1,608,000
Convertible preferred stock, shares issued	1,473	1,608
Convertible preferred stock, shares outstanding	1,473	1,608
Series S 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 110,000	$ 120,000
Convertible preferred stock, shares issued	110	120
Convertible preferred stock, shares outstanding	110	120
Series U Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 270,000	$ 270,000
Convertible preferred stock, shares issued	270	270
Convertible preferred stock, shares outstanding	270	270
Series W 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 696,500	$ 886,500
Convertible preferred stock, shares issued	696.5	886.5
Convertible preferred stock, shares outstanding	696.5	886.5
Series Y Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 2,597,327	$ 2,460,227
Convertible preferred stock, shares issued	25.9	24.6
Convertible preferred stock, shares outstanding	25.9	24.6
Series D Preferred Stock
Preferred stock, shares issued	31,500,000	315,000,000
Preferred stock, shares outstanding	31,500,000	315,000,000
Series C Preferred Stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Current Liabilities
Convertible promissory notes, net of discount (in Dollars per share)	$ 0	$ 0
Long Term Liabilities
Convertible promissory notes, net of discount (in Dollars per share)	$ 0	$ 0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenue		$ 6,573	$ 6,573	$ 13,146
Cost of revenue	6,552	6,463	13,134	13,153
Gross (loss) profit	(6,552)	110	(6,561)	(7)
Operating expenses
Selling and marketing expenses	605,918	605,636	1,132,558	1,402,255
General and administrative expenses	730,573	638,601	1,623,873	1,665,057
Total Operating expenses	1,336,491	1,244,237	2,756,431	3,067,312
Loss from Operations	(1,343,043)	(1,244,127)	(2,762,992)	(3,067,319)
OTHER INCOME (EXPENSE)
Other income		23,416		23,416
Impairment of receivable from SPAC				(50,000)
Gain on write off of loans payable	30,646		30,646
Unrealized loss on investment securities				(4,521)
(Loss) gain on conversion of stock	567,500	(1,802,443)	1,255,178	5,403,828
Gain (loss) on net change in derivative liability and conversion of debt	6,173,683	(1,049,498)	(6,593,511)	2,825,879
Interest and dividend expense	(165,585)	(239,105)	(352,567)	(462,545)
TOTAL OTHER INCOME (EXPENSE)	6,606,244	(3,067,630)	(5,660,254)	7,736,057
Net income (loss) from continuing operations	5,263,201	(4,311,757)	(8,423,246)	4,668,738
Net loss from assets held-for-sale	(1,655,853)	(3,373,086)	(3,865,689)	(9,271,546)
Net income (loss)	$ 3,607,348	$ (7,684,843)	$ (12,288,935)	$ (4,602,808)
Basic earnings (loss) per share from continuing operations (in Dollars per share)	$ 0	$ 0	$ (0.01)	$ 0
Basic (loss) earnings per share from assets held-for-sale (in Dollars per share)	0	0	0	(0.01)
BASIC (in Dollars per share)	$ 0	$ (0.01)	$ (0.01)	$ (0.01)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC (in Shares)	1,558,824,206	1,195,322,992	1,501,184,304	1,243,518,367

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Diluted (loss) earnings per share from continuing operations	$ 0	$ 0	$ (0.01)	$ 0
Diluted (loss) earnings per share from assets held-for-sale	0	0	0	(0.01)
DILUTED	$ 0	$ (0.01)	$ (0.01)	$ (0.01)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, DILUTED (in Shares)	1,558,824,206	1,195,322,992	1,501,184,304	1,243,518,367

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders’ Deficit (Unaudited) - USD ($)	Preferred stock Series O Preferred stock	Preferred stock Series Q Preferred stock	Preferred stock Series R Preferred stock	Preferred stock Series S Preferred stock	Preferred stock Series U Preferred stock	Preferred stock Series Y Preferred stock	Preferred stock Series Z Preferred stock	Preferred stock Series W Preferred stock	Preferred stock	Mezzanine Equity Series O Preferred stock	Mezzanine Equity Series Q Preferred stock	Mezzanine Equity Series R Preferred stock	Mezzanine Equity Series S Preferred stock	Mezzanine Equity Series U Preferred stock	Mezzanine Equity Series Y Preferred stock	Mezzanine Equity Series Z Preferred stock	Mezzanine Equity Series W Preferred stock	Mezzanine Equity	Common stock Series O Preferred stock	Common stock Series Q Preferred stock	Common stock Series R Preferred stock	Common stock Series S Preferred stock	Common stock Series U Preferred stock	Common stock Series Y Preferred stock	Common stock Series Z Preferred stock	Common stock Series W Preferred stock	Common stock	Additional Paid-in- Capital Series O Preferred stock	Additional Paid-in- Capital Series Q Preferred stock	Additional Paid-in- Capital Series R Preferred stock	Additional Paid-in- Capital Series S Preferred stock	Additional Paid-in- Capital Series U Preferred stock	Additional Paid-in- Capital Series Y Preferred stock	Additional Paid-in- Capital Series Z Preferred stock	Additional Paid-in- Capital Series W Preferred stock	Additional Paid-in- Capital	Subscription Payable Series O Preferred stock	Subscription Payable Series Q Preferred stock	Subscription Payable Series R Preferred stock	Subscription Payable Series S Preferred stock	Subscription Payable Series U Preferred stock	Subscription Payable Series Y Preferred stock	Subscription Payable Series Z Preferred stock	Subscription Payable Series W Preferred stock	Subscription Payable	Other Comprehensive loss Series O Preferred stock	Other Comprehensive loss Series Q Preferred stock	Other Comprehensive loss Series R Preferred stock	Other Comprehensive loss Series S Preferred stock	Other Comprehensive loss Series U Preferred stock	Other Comprehensive loss Series Y Preferred stock	Other Comprehensive loss Series Z Preferred stock	Other Comprehensive loss Series W Preferred stock	Other Comprehensive loss	Noncontrolling Interest Series O Preferred stock	Noncontrolling Interest Series Q Preferred stock	Noncontrolling Interest Series R Preferred stock	Noncontrolling Interest Series S Preferred stock	Noncontrolling Interest Series U Preferred stock	Noncontrolling Interest Series Y Preferred stock	Noncontrolling Interest Series Z Preferred stock	Noncontrolling Interest Series W Preferred stock	Noncontrolling Interest	Accumulated Deficit Series O Preferred stock	Accumulated Deficit Series Q Preferred stock	Accumulated Deficit Series R Preferred stock	Accumulated Deficit Series S Preferred stock	Accumulated Deficit Series U Preferred stock	Accumulated Deficit Series Y Preferred stock	Accumulated Deficit Series Z Preferred stock	Accumulated Deficit Series W Preferred stock	Accumulated Deficit	Series O Preferred stock	Series Q Preferred stock	Series R Preferred stock	Series S Preferred stock	Series U Preferred stock	Series Y Preferred stock	Series Z Preferred stock	Series W Preferred stock	Total
Balance at Dec. 31, 2022									$ 3,150									$ 10,866,772									$ 101,337									$ 82,745,503									$ 100,000									$ (132)																		$ (108,966,645)									$ (26,016,787)
Balance (in Shares) at Dec. 31, 2022									32,502,475																		1,013,369,185
Common stock issued for cash per equity financing agreement																											$ 1,865									128,719																																													130,584
Common stock issued for cash per equity financing agreement (in Shares)																											18,645,028
Common stock issued for conversion of Series										$ (40,000)	$ (55,000)	$ (720,000)	$ (50,000)	$ (65,000)	$ (1,330,000)	$ (250,000)			$ 772	$ 1,149	$ 14,648	$ 886	$ 908	$ 23,305	$ 6,173		$ 5,579	$ 39,228	$ 53,851	$ 705,352	$ 49,114	$ 64,092	$ 1,306,695	$ 243,827		161,786																																					$ 40,000	$ 55,000	$ 720,000	$ 50,000	$ 65,000	$ 1,330,000	$ 250,000		$ 167,365
Common stock issued for conversion of Series (in Shares)																			7,722,008	11,490,310	146,475,763	8,864,250	9,078,212	233,043,093	61,728,395		55,788,402																																																						478,402,031
Common stock issued for Series O Preferred stock dividends																											$ 50									(50)
Common stock issued for Series O Preferred stock dividends (in Shares)																											498,280
Common stock issued for conversion settlement																											$ 26,518									(26,518)
Common stock issued for conversion settlement (in Shares)																											265,181,982
Common stock issued for alternative vesting																											$ 1,158									119,382																																													120,540
Common stock issued for alternative vesting (in Shares)																											11,584,932
Common stock issued through a Reg A to investors for cash																											$ 1									37,499																																													37,500
Common stock issued through a Reg A to investors for cash (in Shares)																											7,500
Issuance of Series A Preferred stock granted to Series Y investors																																				23,588																																													23,588
Issuance of Series A Preferred stock granted to Series Y investors (in Shares)									209
Issuance of Series B Preferred stock granted to investors									$ 37																											132,227																																													132,264
Issuance of Series B Preferred stock granted to investors (in Shares)									367,400
Exchange of Series K Preferred stock for Series W Preferred stock																		100,000
Issuances of Series Y Preferred stock through private placement																		376,300
Exchange of Series R Preferred stock for WODI secured convertible note																		(100,000)
Exchange of Series X Preferred stock for WODI secured convertible note																		(250,000)
Return of investment for Series Y Preferred stock																		(10,000)
Shares redeemed/cancelled for Note Purchase Agreement																											$ (58,925)									(5,344,903)																																													(5,403,828)
Shares redeemed/cancelled for Note Purchase Agreement (in Shares)																											(589,253,845)
Net Loss																																																																								(4,602,808)									(4,602,808)
Balance at Jun. 30, 2023									$ 3,187									8,473,072									$ 129,945									80,859,797									100,000									(132)																		(113,569,453)									(32,476,656)
Balance (in Shares) at Jun. 30, 2023									32,870,084																		1,299,440,930
Common stock issued at fair value for services																											$ 4,521									420,405																																													$ 424,926
Common stock issued at fair value for services (in Shares)																											45,217,435																																																						45,217,435
Balance at Dec. 31, 2023									$ 3,150									7,522,722									$ 139,978									81,949,274									100,000									(132)									(2,239,493)									(119,216,735)									$ (39,263,958)
Balance (in Shares) at Dec. 31, 2023									31,501,000																		1,399,782,046
Common stock issued for cash per equity financing agreement (in Shares)																											20,937,829
Common stock issued for conversion of Series										$ (5,000)	$ (20,000)	$ (135,000)	$ (10,000)		$ (440,000)		$ (200,000)		$ 97	$ 458	$ 3,050	$ 227		$ 8,384		$ 4,172		$ 4,903	$ 19,542	$ 131,950	$ 9,773		$ 431,616		$ 195,828																																						$ 5,000	$ 20,000	$ 135,000	$ 10,000		$ 440,000		$ 200,000
Common stock issued for conversion of Series (in Shares)																			965,252	4,576,458	30,496,772	2,272,728		83,840,346		41,715,134
Common stock issued for Series O Preferred stock dividends																											$ 44									(44)
Common stock issued for Series O Preferred stock dividends (in Shares)																											436,819
Common stock issued for conversion settlement																											$ 12,221									(12,221)
Common stock issued for conversion settlement (in Shares)																											122,213,744
Common stock issued for alternative vesting																											$ 2,094									167,505																																													169,599
Common stock issued for alternative vesting (in Shares)																											20,937,829
Exchange of Series K Preferred stock for Series W Preferred stock																		10,000
Issuance of warrants																																				426,230																																													426,230
Issuances of Series Y Preferred stock through private placement																		575,100
Exchange of Series F Preferred stock for Series Q preferred stock																		10,000
Rounding																											(1)																																																						(1)
Shares redeemed/cancelled for Note Purchase Agreement																											$ (13,956)									(1,241,222)																																													(1,255,178)
Shares redeemed/cancelled for Note Purchase Agreement (in Shares)																											(139,560,037)
Net Loss																																																															(354,486)									(11,934,449)									(12,288,935)
Balance at Jun. 30, 2024									$ 3,150									7,307,822									$ 161,309									82,490,747									100,000									(132)									(2,593,979)									(131,151,184)									(50,990,089)
Balance (in Shares) at Jun. 30, 2024									31,501,000																		1,613,089,087
Common stock issued at fair value for services																											$ 4,541									$ 407,613																																													$ 412,154
Common stock issued at fair value for services (in Shares)																											45,411,996

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from continuing operations	$ (8,423,246)	$ 4,668,738
Net loss from assets held-for sale	(3,865,689)	(9,271,546)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,498	15,432
Common and preferred stock issued for services	412,154	424,926
Loss (gain) on net change in valuation of derivative liability	6,593,511	(2,825,879)
Stock based compensation expense	169,599	120,540
Preferred stock incentive compensation expense		155,852
Debt discount recognized as interest expense	90,000
Net unrealized loss on fair value of securities		4,521
Impairment of receivable from SPAC	1,128,000	2,650,986
Conversion and settlement value loss on WODI	1,297,000	6,037,589
Gain on redemption of common stock	(1,255,178)	(5,403,828)
Gain on write-off of payable	(30,646)
Contracts receivable	262,091	1,061,010
Contract asset	(21,804)	390,206
Prepaid expenses and other assets	(45,401)	14,226
Other assets	(18,000)	(27,694)
Accounts payable	303,913	(1,512,839)
Accrued expenses	981,394	401,092
Contract liabilities	273,393	(208,564)
Tax liability 83(b)		(2,000)
Trust escrow		24,500
Net cash used in operating activities	(2,134,412)	(3,282,732)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of SPAC notes payable	(1,128,000)	(2,650,986)
Payments received on long term asset	66,000	230,428
Purchase of fixed assets	(9,000)	(9,000)
Net cash used in investing activities	(1,071,000)	(2,429,558)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on loan payable, SBA	(1,327)	(1,273)
Proceeds from line of credit		200,994
Payments on line of credit	(125,745)
Proceeds from loans, merchant cash advance	135,000
Payments on loans, merchant cash advance	(189,445)
Equity financing through the purchase of common shares		168,084
Net payments on cumulative preferred stock dividends	89,812	9,761
Proceeds from convertible secured promissory notes	2,042,500	4,994,000
Proceeds from issuance of warrants	426,230
Net proceeds for issuance of preferred stock for cash - mezzanine classification	575,100	366,300
Net cash provided by financing activities	2,952,125	5,737,866
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(253,287)	25,576
CASH AND CASH EQUIVALENTS BEGINNING OF PERIOD	488,830	1,354,814
CASH AND CASH EQUIVALAENTS END OF PERIOD	235,543	1,380,390
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and dividends paid	28,817	255,983
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees		167,365
Issuance of Series O dividends	44	50
Preferred stock converted to common stock - mezzanine	810,000	2,510,000
Exchange of Series R Preferred Stock for WODI secured convertible note		100,000
Exchange from liability to mezzanine	20,000
Common stock issued as settlement	12,221	26,518
Exchange of Series X Preferred Stock for WODI secured convertible note		250,000
Shares issued for alternate vesting		1,158
Redemption of shares for secured promissory notes		58,925
Conversion of liability classified preferred stock to mezzanine		$ 100,000

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2024
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) are unaudited and, in the opinion of management, include all adjustments, including all normal recurring items for a fair statement of the Company’s financial position and results of operations for all periods presented. All intercompany balances and transactions are eliminated in consolidation. The consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2023 (the Annual Report). The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The consolidated financial statements included in this report have been prepared consistently with the accounting policies described in the Annual Report, except as noted, and should be read together with the Annual Report. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for fiscal year ending December 31, 2024. OriginClear was founded as OriginOil® in 2007 and began trading on the OTC in 2008. In 2015, it was renamed OriginClear® to reflect its new mission to develop breakthrough businesses in the industrial water sector. Today, OriginClear is structured as the Clean Water Innovation Hub™ and intends to leverage its retail investor development capabilities to help bring potentially disruptive companies to market. For the foreseeable future, OriginClear will focus its entire capabilities to the success of its subsidiary, Water On Demand, Inc. (“WODI”). In 2023, OriginClear combined three of its operating divisions into WODI in anticipation of a merger of such subsidiary with Fortune Rise Acquisition Corp (“FRLA”) a Special Purpose Acquisition Company. The definitive merger agreement between WODI and FRLA was announced on October 24, 2023: https://www.originclear.com/company-news/originclears-water-on-demand-and-fortune-rise-acquisition-corporation-announce-business-combination-to-create-nasdaq-listed-company. WODI is now composed of three operating units: Modular Water Systems (“MWS”), Progressive Water Treatment (“PWT”), and Water on Demand (“WOD”), the last being a development stage business. ● PWT ● MWS ● WOD Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. These financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2023, expressed substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern and appropriateness of using the going concern basis depend on, among other things, achieving profitable operations and receiving additional cash infusions. During the six months ended June 30, 2024, the Company obtained funds from the issuance of convertible note agreements and from sale of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. The Company generated revenue of $6,573 and its operating divisions have standing purchase orders and open invoices with customers, which will provide funds for operations. Management believes the existing shareholders, the prospective new investors, and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. However, no assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations in the case of debt financing or cause substantial dilution for our stockholders in the case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies This summary of significant accounting policies is presented to assist in understanding the Company’s consolidated financial statements. The consolidated financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to GAAP and have been consistently applied in the preparation of the consolidated financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its subsidiaries: WODI, (which consists of operating divisions Progressive Water Treatment, Modular Water Systems and Water On Demand), Water On Demand #1, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to, impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share is calculated by dividing net income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated similarly to basic earnings per share, except that the denominator is adjusted to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. For the six months ended June 30, 2024, and 2023, the Company’s diluted earnings per share were the same as basic loss per share because the inclusion of any potential common shares would have been anti-dilutive due to the Company’s net losses. The Company excludes issuable shares from warrants, convertible notes, and preferred stock, if their impact on the loss per share is anti-dilutive, and includes the issuable shares if their impact is dilutive. Loss per share For the Six Months Ended June 30, 2024 2023 Loss to common shareholders (Numerator)- continuing operations $ (8,423,246 ) $ 4,668,738 Loss to common shareholders (Numerator) - related to assets held-for-sale (3,865,689 ) (9,271,546 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 1,501,184,304 1,243,518,367 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. Revenue Recognition We recognize revenue in accordance with Accounting Standards Codification (“ASC”) ASC 606, Revenue from Contract with Customers (“ASC 606”). We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Nature of Contracts and Performance Obligations Engineered Water Treatment Solutions (PWT) We design, manufacture, and install our customer water treatment systems for municipalities, industrial clients, and commercial entities. Our performance obligations typically include the delivery and installation of water treatment systems that meet specific customer requirements. Revenue from these contracts is recognized over time as performance obligations are satisfied, using a cost-cost input method, which reflects the extent of progress towards completion. The transaction price is determined based on fixed fees agreed upon in the contract, and any variable considerations, such as performance bonuses, are estimated at contract inception and constrained to avoid significant reversals. Sales Price Calculation The transaction price for each contract is determined based on the agreed-upon terms with the customer, indicating fixed fees and variable consideration where applicable. Variable consideration is estimated at contract inception and constrained to the extent that is it probable that significant reversal of recognized revenue will not occur when the uncertainty is resolved. Contract Modifications Contract modifications are accounted for when they create or change existing enforceable rights and obligations. The impact of modifications on transaction prices and performance obligations is recognized in the period when the modifications are approved. Significant Judgements and Estimates ● Estimating Progress Towards Completion: For long-term contracts, we use the cost-to-cost method to estimate progress towards completion, considering total costs incurred relative to total estimated costs to complete the project. ● Variable Consideration: Estimates to variable considerations are constrained to ensure that recognized revenue is not subject to significant reversals in future periods. Material Rights and Obligations Our contracts may include material rights for customers to receive effective water treatment solutions and ongoing maintenance services. Our obligations include designing, manufacturing, delivering, installing, and maintaining water treatment systems, as well as providing continuous water treatment services under the DBOO model. In accordance with ASC 280-10-50-38 through 50-41, we provide entity wide disclosures, including: ● Product and Services: Our products and service offering include comprehensive water treatment solutions, such as design, manufacturing, and outsourced water treatment services. ● Geographical Areas: We primarily serve customers in the United States and Canada, with some international clients in Japan, Argentina and the Middle East. Significant Customers Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions are estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based on progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations and not allocated to contract costs. We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with ASC 606. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements, which generally require billing on a progressive basis as work is completed. Credit is extended based on evaluation of each client’s financial condition, and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of past-due receivables from customers on a monthly basis. An allowance against uncollectible items is recorded for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. Reasonable means of collection may include multiple follow-up communications, renegotiation of payment terms, and if necessary, legal action. The allowance for doubtful accounts was $355,453 and $379,335 as of June 30, 2024, and December 31, 2023, respectively. The net contract receivable balance was $1,247,416 and $1,509,504 as of June 30, 2024, and December 31, 2023, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations.” Under this method, total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price allocation uses the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed, is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year, or whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill as of June 30, 2024, and 2023, respectively, and determined there was no impairment of indefinite lived intangibles and goodwill. Prepaid Expenses The Company records expenditures that have been paid in advance for goods or services to be received in the future as prepaid expenses. These prepaid expenses are initially recorded as assets because they have future economic benefits. They are expensed as the benefits are realized. The prepaid expenses balance was $45,401 and $0 as of June 30, 2024, and December 31, 2023, respectively. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and improvement are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 3-7 years Computer software 3 years Vehicles 3-6 years Leasehold improvements 2-5 years or lease term June 30, December 31, 2024 2023 Machinery and equipment $ 383,571 $ 383,569 Computer equipment and software 66,491 66,493 Vehicles 64,277 64,276 Demo Units 36,139 36,139 Furniture and fixtures 29,809 29,810 Leasehold improvements 26,725 26,725 Gross property and equipment 607,012 607,012 Less accumulated depreciation (474,774 ) (460,276 ) Net property and equipment $ 132,238 $ 146,736 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the event that the facts and circumstances indicate that the cost of any long-lived assets be impaired, an evaluation of recoverability would be performed in accordance with GAAP. Depreciation expense during the six months ended June 30, 2024, and 2023, was $14,498 and $15,432, respectively. Long Term Asset Held for Sale On March 1, 2021, the Company issued 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per the terms of a Securities Purchase Agreement (the “SPA”). According to the SPA, the Purchaser received 630 shares of Series T Preferred Stock, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share. These warrants are exercisable at any time, in whole or in part. In lieu of the purchase price for the Series T Preferred Stock, the Purchaser transferred to the Company real property with an aggregate value of $630,000. This property, based on a independent appraisal, consisted of residential real estate in Buenos Aires, Argentina, valued at $580,000, and eight undeveloped lots in the Terralta private neighborhood development, valued at $50,000. The property was recorded on the condensed consolidated balance sheet as long-term asset held for sale at $630,000. The property was listed for sale in July 2021. Due to impairment indicators during the year ended December 31, 2021, the Company reduced the value of the asset from $630,000 to $514,000, recording an impairment of $116,000 in the consolidated financial statements. During the year ended December 31, 2022, after evaluating several offers, the Company accepted an offer of $400,000, which was $114,000 below the adjusted value, reflecting the real estate market conditions in Buenos Aires, Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the value of the asset held for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted, and the related warrants expired by during the period ended December 31, 2022. In January 2023, the Company accepted the offer and on April 8, 2023, executed a deed for the sale of the property for $400,000. The payment terms included an initial payment of $235,000, with the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each. The initial payment was received by SMS Argentina (“SMS”), an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the property. SMS remitted taxes due on the transaction to the Federal Administration of Public Income (“AFIP”), the taxation authority in Argentina. On June 21, 2023, the Company received a net payment of $164,935, after taxes and closing fees totaling $65,493. During 2023, the Company recorded a receivable of $169,572 for the remaining amount on the consolidated financial statements. As of June 30, 2024, the balance of the receivable was $33,000 which is reflected on the condensed consolidated balance sheet. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board (“FASB”), where the value of the award is measured on the grant date and recognized over the vesting period. For stock option and warrant grants issued and vesting to non-employees, the Company follows the authoritative guidance of the FASB, where the value of the stock compensation is determined based upon the measurement date, which is either (a) the date at which a performance commitment is reached, or (b) the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges are generally amortized over the vesting period on a straight-line basis. If there are no future performance requirements by the non-employee, option grants vest immediately, and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all its financial instruments to determine if they qualify as derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments accounted for as liabilities, the derivative instrument is initially recorded at its fair value and revalued at each reporting date. Changes in the fair value are reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a probability-weighted average series Binomial lattice option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including the determination of whether they should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified on the condensed consolidated balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the condensed consolidated balance sheet, where it is practicable to estimate that value. As of June 30, 2024, the balances reported for cash, contract receivables, costs in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value due to their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1: Observable inputs such as quoted prices for identical instruments in active markets; ● Level 2: Inputs other than quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active. ● Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of June 30, 2024: Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, June 30, 2024 $ 39,367 $ 39,367 $ - $ - Total (Level 1) (Level 2) (Level 3) Convertible notes liability $ 14,101,479 $ - $ - $ 14,101,479 Warrants liability 234,791 - - 234,791 Total derivative liability, June 30, 2024 14,336,270 - - 14,336,270 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2024 $ 7,742,759 Net loss on conversion of debt and change in derivative liabilities 6,593,511 Balance as of June 30, 2024 $ 14,336,270 For the purpose of determining the fair market value of the derivative liability, the Company used a Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: June 30, 2024 Risk free interest rate 4.53% - 5.01% Stock volatility factor 101.9% - 218.8% Weighted average expected option life (in years) .5 - 4.5 Expected dividend yield None Segment Reporting The Company operates in a single business segment based on its organizational structure and the manner in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments, except those accounted for under the equity method of accounting, or those that result in consolidation of the investee, to be measured at fair value, with changes in fair value recognized in net income. It also mandates the use the exit price notion for measuring the fair value of financial instruments for disclosure purposes and requires the separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. Additionally, it eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value of financial instruments measured at amortized cost. The Company evaluated the impact of this standard on the condensed consolidated financial statements and determined it had a significant impact. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, with unrealized gains on these securities recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of intellectual property (“IP”) is distinct from the non-license goods or services and possesses significant standalone functionality that provides a benefit or value to the customer. This functionality does not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, revenue is generally recognized when the license is delivered. Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation used in the current condensed consolidated financial statements for comparative purposes. These reclassifications had no material effect on the Company’s previously issued financial statements. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work-in-process includes the cost of materials and labor related to the construction of equipment to be sold to customers. Recently Issued Accounting Pronouncements Management has reviewed recently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

WODI Assets and Liabilities Hel

WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations	6 Months Ended
	Jun. 30, 2024
WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations [Abstract]
WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations	3. WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations On September 21, 2023, WODI entered into a merger agreement with PWT, whereby WODI was merged with PWT. This merger was completed to create better enterprise value for a potential merger opportunity with FRLA. In connection with the merger, PWT changed its name to Water on Demand, Inc. On September 28, 2023, the Letter of Intent (“LOI”) executed on January 5, 2023, with WODI was amended to designate PWT as the new target of the acquisition. Under the amended LOI, FRLA proposed to acquire all the outstanding securities of the new combined WODI/PWT entity, based on certain material financial and business terms and conditions being met. The LOI is not binding on the parties and is intended solely to guide good-faith negotiations toward definitive agreements. On October 24, 2023, FRLA and WODI entered into a definitive business combination agreement (the “BCA”). The transaction represents a pro forma equity valuation of approximately $72 million for the combined company, assuming no further redemptions of FRLA public shares by FRLA’s public shareholders. On October 25, 2023, at the Special Meeting, FRLA shareholders approved a proposal to extend the period FRLA has to consummate its initial business combination by up to twelve-one-month extensions, from November 5, 2023, to November 5, 2024, subject to certain conditions. On February 14, 2024, the Company and FRLA filed a registration statement on Form S-4 with the SEC which includes a preliminary proxy statement and prospectus in connection with the proposed business combination with WODI. In accordance with ASC 205-20, a disposal of a component or a group of components should be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when a component of or group of components meets the initial criteria for classification of held for sale to be classified as held for sale. Per the initial criteria for classification of held for sale, a component or a group of components, or a business or nonprofit activity (the entity to be sold), should be classified as held for sale in the period in which all of the following criteria are met: ● Management, having the authority to approve the action, commits to a plan to sell the entity to be sold. ● The entity to be sold is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such entities to be sold. ● An active program to locate a buyer or buyers and other actions required to complete the plan to sell the entity to be sold have been initiated. ● The sale of the entity to be sold is probable (the future event or events are likely to occur), and transfer of the entity to be sold is expected to qualify for recognition as a completed sale, within one year, unless events or circumstances beyond an entity’s control extend the period required to complete the sale as discussed below. ● The entity to be sold is being actively marketed for sale at a price that is reasonable in relation to its current fair value. ● Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. Since the proposed business combination of WODI with FRLA meets all the initial criteria for classification of held for sale, the assets, liabilities, and operating results of WODI have been classified as held for sale in the period ending June 30, 2024. The condensed consolidated financial statements for the prior year ending in December 31, 2023, have been adjusted to reflect comparable information as follows: Assets and Liabilities Held-For-Sale June 30, December 31, 2024 2023 CURRENT ASSETS Cash $ 202,644 $ 374,192 Contracts receivable, net allowance of $355,453 and $379,335, respectively (Note 2) 1,247,416 1,509,504 Contract assets (Note 7) 476,906 455,102 Prepaid expenses 34,354 - Total Current Assets Held-For-Sale 1,961,320 2,338,798 NET PROPERTY AND EQUIPMENT HELD-FOR-SALE 2,006 3,370 NON-CURRENT ASSETS HELD-FOR SALE SPAC Class B common shares purchase cost (Note 10) 400,000 400,000 Security deposit 18,000 - 418,000 400,000 CURRENT LIABILITIES HELD-FOR-SALE Accounts payable and other payable $ 1,459,460 $ 1,335,211 Accrued expenses 1,992,046 1,103,159 Contract liabilities (Note 7) 1,619,759 1,346,366 Tax liability 83(b) 13,600 13,600 Customer deposit 143,503 143,503 Warranty reserve 20,000 20,000 Line of credit (Note 11) 53,063 178,808 Secured loans payable 146,250 110,695 Convertible secured promissory notes (Note 6) 20,068,589 16,729,089 Total Current Liabilities Held-For-Sale $ 25,516,270 $ 20,980,431 Net Loss from Assets Held-For-Sale Six Months Ended 2024 2023 Sales $ 2,604,196 $ 3,823,932 Cost of goods sold 2,332,346 3,513,086 Gross Profit 271,850 310,846 Operating Expenses Selling and marketing expenses 94,671 42,988 General and administrative expenses 578,784 560,247 Total Operating Expenses 673,455 603,235 Loss from Operations (401,605 ) (292,389 ) OTHER INCOME (EXPENSE) Other income 1,143 126,879 Impairment of receivable from SPAC (1,128,000 ) (2,600,985 ) Conversion and settlement value added to note purchase agreements (see Note 6) (1,297,000 ) (6,037,589 ) Preferred stock compensation expense - (155,852 ) Interest expense (1,040,227 ) (311,610 ) TOTAL OTHER (EXPENSE) INCOME (3,464,084 ) (8,979,157 ) NET LOSS FROM ASSETS-HELD-FOR-SALE $ (3,865,689 ) $ (9,271,546 )

Capital Stock

Capital Stock	6 Months Ended
	Jun. 30, 2024
Capital Stock [Abstract]
Capital Stock	4. Capital Stock OriginClear, Inc. Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, has no liquidation preference, and the shares do not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of the stockholders. The purchase price of the Series C preferred stock was $0.0001 per share, representing a total purchase price of $0.10 for 1,000 shares. As of June 30, 2024, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of outstanding common stock, which may be increased to 9.99% at the holder’s discretion upon 61 days’ written notice. As of June 30, 2024, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares do not carry any voting rights. The Company may, in its sole discretion, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. During the six months ended June 30, 2024, the Company exchanged an aggregate of 10 shares of Series F preferred stock for 10 shares of Series Q preferred stock. No gain or loss was recognized in the exchange. As of June 30, 2024, the Company had 50 outstanding shares of Series F preferred stock, which the Company was required to, and failed to, redeem on September 1, 2020, and remains in default for an aggregate redemption price (equal to the stated value) of $50,000. Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000. Holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, at its sole discretion, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of June 30, 2024, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, for an aggregate redemption price (equal to the stated value) of $25,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I with a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I preferred stock is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I preferred stock at any time at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I preferred stock two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021, and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. As of June 30, 2024, there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem by June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000. Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J, with a stated value of $1,000 per share. Holders of Series J preferred stock are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J Certificate of Designation (“COD”), which includes certain make-good shares for certain prior investors. As of June 30, 2024, there were 210 shares of Series J preferred stock issued and outstanding. Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K, with a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K preferred stock is not entitled to voting rights except as required by law and is not convertible into common stock. The Company has the right to redeem the Series K preferred stock at any time at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem the Series K shares two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuance of the shares was accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2024, the Company exchanged an aggregate of 10 shares of Series K preferred stock for 10 shares of Series W preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 297.15 shares of Series K preferred stock issued and outstanding, which the Company was required to, and failed to redeem by April 24, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $297,150. Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L, with a stated value of $1,000 per share. Holders of Series L preferred stock are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock pursuant to the Series L COD, which includes certain make-good shares for certain prior investors. As of June 30, 2024, there were 320.5 shares of Series L preferred stock issued and outstanding. Series M Pursuant to the Amended and Restated Certificate of Designation of Series M Preferred Stock filed with the Secretary of State of Nevada on July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M preferred stock, with a stated valued of $25per share. The Series M preferred stock is not convertible into common stock. Holders of outstanding shares of Series M preferred stock are entitled to receive dividends at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of dividends on common stock. The Series M preferred stock is entitled to a liquidation preference equal to $25 per share plus any declared but unpaid dividends before any payments to holders of common stock. The Series M preferred stock does not have pre-emptive or subscription rights, and there are no sinking fund provisions applicable to it. The Series M preferred stock does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the COD (see ITEM 15. Exhibit 3.29). The Company may, at its sole discretion, redeem any or all of the outstanding shares of Series M Preferred Stock at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of June 30, 2024, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O preferred stock, with a stated value of $1,000 per share. Holders of Series O preferred stock are entitled to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O preferred stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O preferred stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to it. The Series O preferred stock does not have voting rights except as required by law. The Series O preferred stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value by the conversion price, provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series O preferred stock at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the six months ended June 30, 2024, the Company issued an aggregate of 436,819 shares of common stock in prorated 4% annualized dividends, recorded as interest expense. The shares were issued within the terms of the agreement and no gain or loss was recognized. During the six months ended June 30, 2024, the Company issued an aggregate of 965,252 shares of common stock upon conversion of 5 shares of Series O preferred stock. There was no gain or or loss recognized. As of June 30, 2024, there were 185 shares of Series O preferred stock issued and outstanding. Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P preferred stock with a stated value of $1,000 per share. Holders of Series P preferred shares are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series P preferred stock is convertible into stock of the Company pursuant to the Series P COD, which includes certain make-good shares for certain prior investors, provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P preferred stock entitles the holders to a payment on an as-converted and pari-passu basis with the common stock upon any liquidation. The Series P preferred stock has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable. The Series P preferred stock votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of June 30, 2024, there were 30 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q Preferred Stock. The Series Q Preferred Stock has a stated value of $1,000 per share and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable. The Series Q Preferred Stock does not have voting rights except as required by law. The Series Q Preferred Stock is convertible into common stock in an amount determined by dividing 200% of the stated value by the conversion price, provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series Q Preferred Stock at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the six months ended June 30, 2024, the Company issued an aggregate of 4,576,458 shares of common stock upon conversion of 20 shares of Series Q preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 410 shares of Series Q preferred stock issued and outstanding. Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series R at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. During the six months ended June 30, 2024, the Company issued an aggregate of 30,496,772 shares of common stock upon conversion of 135 shares of Series R preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 1,473 shares of Series R preferred stock issued and outstanding. Series S On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as required by law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value by the conversion price, provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series S at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months ended June 30, 2024, the Company issued an aggregate of 2,272,728 shares of common stock upon conversion of 10 shares of Series S preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 110 shares of Series S preferred stock issued and outstanding. Series U On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U, with a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that conversion does not result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. As of June 30, 2024, there were 270 shares of Series U preferred stock along with 1,511,500 warrants with a fair value of $0 (with exercise price of $1) issued and outstanding. These warrants associated with Series U were valued using the Black Scholes model (See Note 5). Series W On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W, with a stated value of $1,000 per share. Series W holders are entitled to cumulative dividends in cash at an annual rate of 12%, payable quarterly. The Series W holders are not entitled to any voting rights except as required by law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value by the conversion price; provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock. The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months ended June 30, 2024, the Company issued an aggregate of 41,715,134 shares of common stock upon conversion of 200 shares of Series W preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 696.5 shares of Series W preferred stock issued and outstanding. Series Y On December 6, 2021, the Company designated 3,000 shares of preferred stock as Series Y, with an original issue price of $100,000 per share. Holders are entitled to receive, on a pro rata and pari passu basis, annual distribution of up to 25% of the annual net profits of newly established, wholly-owned, WOD subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series Y holders are not entitled to any voting rights except as required by law. The Series Y is convertible into common stock of the Company pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right to redeem the Series Y at any time at a redemption price equal to, if paid in cash, the original issue price plus any accrued but unpaid distributions of 25% of the subsidiary’s annual net profits. Additionally, the Series Y holders received shares of Series A preferred stock in the Company’s subsidiary Water On Demand, Inc or warrants to purchase common shares in WODI. During the six months ended June 30, 2024, the Company received aggregate funding in the amount of $575,100 through the sale of Series Y preferred stock and issued an aggregate of 83,840,346 shares of common stock upon conversion of 4.4 shares of Series Y preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of June 30, 2024, there were 25.95 shares of Series Y preferred stock along with 55,614,616 warrants with a fair value of $199,084 (with exercise prices between $0.13 and $0.25) issued and outstanding. The warrants were valued using the Black Scholes model (See Note 5). Series Z On February 11, 2022, the Company designated 25 shares of preferred stock as Series Z, with an original issue price of $10,000 per share. The Series Z holders were not entitled to dividends or any voting rights. The Series Z was convertible into common stock of the Company pursuant to the Series Z COD, provided that conversion does not result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). On February 18, 2022, the Company issued and sold to the Purchaser an aggregate of 25 shares of Series Z preferred stock and issued an aggregate of warrants. 25 shares of Series Z were converted to common stock during the year ended As of June 30, , there were 2,500,000 warrants with a fair value of $7,730 (with an exercise price of $0.10) and no shares of Series Z preferred stock issued and outstanding. . As of June 30, 2024, the Company accrued aggregate dividends in the amount of $613,215 for all series of preferred stock. During the six months ended June 30, 2024, the Company redeemed an aggregate of 139,560,037 shares of common stock at a price of $0.01 per share and recognized a gain of $1,255,178 in the condensed consolidated statements of operations relating to settlement and conversion agreements with certain WODI convertible secured promissory note holders. The Series J, Series L, Series M, Series O, Series P, Series Q, Series R, Series S, Series U, Series W, Series Y, and Series Z preferred stock are accounted for outside of permanent equity due to the terms of conversion at a market component or stated value of the preferred stock. WODI Preferred Stock On April 22, 2022, WODI authorized 50,000,000 shares of preferred stock with a par value of $0.0001per share. Due to WODI’s merger with PWT on September 21, 2023 (See Note 10 ) OriginClear, Inc. Common Stock Six Months Ended June 30, 2024 The Company issued 45,411,996 shares of common stock for services at a fair value of $412,154, at share prices ranging from $0.0065 - $0.012. The Company issued 436,819 shares of common stock for Series O preferred stock dividends payable. The Company issued 122,213,744 shares of common stock for settlement of conversion agreements at a fair value of $12,221. The Company issued 20,937,829 shares of common stock for alternate vesting at a fair value of $169,596. The Company issued 163,866,690 shares of common stock upon conversion of $810,000 of preferred stock. The Company redeemed 139,560,037 shares of common stock at a market price of $0.01 per share with a gain in the amount of $1,255,178. Six Months Ended June 30, 2023 The Company issued 18,645,028 shares of common stock for cash, through an equity financing agreement for a total aggregate of $130,584 based upon conversion prices ranging from $0.0064 to $0.00816. The Company issued 55,788,402 shares of common stock upon conversion of convertible promissory note in the amount of principal of $91,000, plus accrued interest of $76,365, for a total aggregate of $167,365 based upon a conversion price of $0.0085. The shares were issued within the terms of the agreements and no gain or loss was recognized. The Company issued 45,217,435 shares of common stock for services at fair value of $424,926, at share prices ranging from $0.0051 to $0.0135. The Company issued 498,280 shares of common stock for Series O preferred stock dividends payable. The Company issued 11,584,932 shares of common stock for alternate vesting at a fair value of $1,158. The Company issued 265,181,982 shares of common stock for settlement of conversion agreements at a fair value of $26,518. The Company issued 478,402,031 shares of common stock upon conversion of $2,510,000 of preferred stock. The shares were issued within the terms of the agreements and no gain or loss was recognized. The Company redeemed 589,253,845 shares of common stock at a market price of $0.01 per share in the amount of $5,403,828. WODI Common Stock Non-controlling Interest As of June 30, 2024, WODI had issued and outstanding shares, of which, the Company owns 90.83%, with a minority, non-controlling interest of 9.17%. The following table shows WODI ownership percentage as of June 30, 2024: WODI common stock holders Ownership OriginClear, Inc. 90.83 % Prior Reg A Holders 0.19 % Prior Series A Holders 3.87 % Prior Series B Holders 5.11 % Total 100 %

Restricted Stock Grants and War

Restricted Stock Grants and Warrants	6 Months Ended
	Jun. 30, 2024
Restricted Stock Grants and Warrants [Abstract]
Restricted Stock Grants and Warrants	5. Restricted Stock Grants and Warrants Restricted Stock Grants to CEO, the Board, Employees and Consultants Between May 12, 2016, and August 4, 2022, the Company entered into Restricted Stock Grant Agreements (“ RSGAs”) with its Chief Executive Officer, the Board, employees, and consultants to create management incentives aimed at improving the Company’s economic performance and increasing its value and stock price. All shares issuable under the RSGAs are performance-based shares. The RSGAs provide for the issuance of shares of the Company’s common stock provided certain milestones are met. These milestones are (a) if the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, and b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization The Company has not recognized any costs associated with these milestones because achievement is not probable. On August 14, 2019, the Board of Directors approved an amendment to the RSGAs to include an alternative vesting schedule for the grantees, and on January 26, 2022, the Company amended the procedures for processing the RSGAs. If the fair market value of the Company’s common stock on the date the shares vest is less than the fair market value of the Company’s common stock on the effective date of the RSGAs, the number of vested shares issuable (assuming all conditions are satisfied per terms of the alternative vesting schedule) shall be increased so that the aggregate fair market value of vested shares on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will follow the original RSGAs terms. Shares are issued under the alternate vesting schedule per terms of the agreements after electing and qualifying requirements are met. During the six months ended June 30, 2024, upon qualifying under the alternative vesting schedule, the Company issued an aggregate of 20,937,829 shares relating to the RSGAs and recognized an aggregate expense of $169,599 which is reflected on the financial statements as stock-based compensation. Warrants During the six months ended June 30, 2024, the Company issued 1,427,049 warrants for proceeds in the amount of $426,230 and issued 2,020,000 purchase warrants associated with the preferred stocks, with an exercise price of $1.00 and a term of three years. A summary of the Company’s warrant activity and related information for the six months ended June 30, 2024, is as follows: Weighted average Number of exercise Warrants price Outstanding - beginning of period 64,401,089 $ 0.1383 Granted 4,600,800 $ 0.1250 Exercised - $ - Expired (48,500 ) $ 1.0000 Outstanding - end of period 68,953,389 $ 0.1368 At June 30, 2024, the weighted average remaining contractual life of warrants outstanding: Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.0200 600,000 600,000 2.17 $ 0.1000 2,500,000 2,500,000 6.91 $ 0.2500 3,760,000 3,760,000 2.64 $ 0.0275 8,727,273 8,727,273 3.20 $ 0.1250 51,854,616 51,854,616 2.47 $ 1.0000 1,511,500 1,511,500 0.23 68,953,389 68,953,389 The derivative liability recognized in the financial statements for the warrants as of June 30, 2024 was $234,791. At June 30, 2024, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	6 Months Ended
	Jun. 30, 2024
Convertible Promissory Notes [Abstract]
Convertible Promissory Notes	6. Convertible Promissory Notes OriginClear, Inc. As of June 30, 2024, the outstanding convertible promissory notes are summarized as follows: Convertible promissory notes $ 2,617,691 Less current portion 597,944 Total long-term liabilities $ 2,019,747 Maturities of long-term debt for the next three years are as follows: Period ending June 30, Amount 2024 (remaining 6 months) - 2025 82,472 2026 1,875,000 2027 - 2028 62,275 $ 2,019,747 2014-2015 Notes On various dates from November 2014 through April 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), which matured on various dates and were extended for an additional sixty months from the effective date of each note. The 2014-2015 Notes bear interest at 10% per year, with maturity dates extended to November 2023 through April 2026. These notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines due to the reset conversion features. As of June 30, 2024, the 2014-2015 Notes had an aggregate remaining balance of $683,700, classified as long term. OID Notes The unsecured original issue discount (OID) convertible promissory notes had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on June 30, 2023, and were extended to June 30, 2028. These notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620 amended to the lesser of $5,600 per share, fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the OID Notes. During the year ended December 31, 2023, an addendum to the OID Notes was effectuated to accrue interest on a monthly basis. As of June 30, 2024, the remaining balance on the OID Notes was $62,275, classified as long- term. 2015 Notes The Company issued various unsecured convertible promissory notes (the “2015 Notes”) on various dates, with the last issued in August 2015. The 2015 Notes matured and were extended from the date of each tranche through maturity dates ending in February 2026 through August 2026, bearing interest at 10% per year. These notes are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance. The conversion feature of the 2015 Notes was considered a derivative due to the reset conversion features. As of June 30, 2024, the 2015 Notes had an aggregate remaining balance of $1,200,000, classified as long-term. Dec 2015 Note The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. Initially accounted for under ASC 470 with a beneficial conversion feature, it was later accounted for under ASC 815, as a derivative due to reset conversion features. The Dec 2015 Note has zero stated interest rate, with a conversion price equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of June 30, 2024, the remaining balance on the Dec 2015 Note was $167,048, classified as short-term. Sep 2016 Note The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. Initially accounted for under ASC 470 with a beneficial conversion feature, it was later accounted for under ASC 815 as a derivative due to reset conversion features. The Sep 2016 Note has zero stated interest rate, with a conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of June 30, 2024, the remaining balance on the Sep 2016 Note was $430,896, classified as short-term. Nov 2020 Note On November 19, 2020, the Company entered into an unsecured convertible promissory note (the “Nov 2020 Note”) for $50,000. The Nov 2020 Note had an original maturity date of November 19, 2021 and was extended for an additional sixty months from the maturity date, bearing interest at 10% per year. The Nov 2020 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share, 50% of the lowest trade price of common stock recorded on any trade after the effective date, or the lowest effective price per share granted. If shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day is assessed for each day after the third business day until delivery. The conversion feature was considered a derivative due to the reset conversion features. As of June 30, 2024, the remaining balance on the Nov 2020 Note was $13,772, classified as long-term. Jan 2021 Note On January 25, 2021, the Company entered into an unsecured convertible promissory note (the “Jan 2021 Note”) for $60,000. The Jan 2021 Note had an original maturity date of January 25, 2022, and was extended for an additional sixty months from the maturity date, bearing interest at 10% per year. The Jan 2021 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of $0.05 per share, 50% of the lowest trade price of common stock recorded on any trade after the effective date, or the lowest effective price per share granted. If shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until delivery. The conversion feature of the Jan 25 Note was considered a derivative due to the reset conversion features. As of June 30, 2024, the balance of the Jan 2021 Note was $60,000, classified as long-term. Evaluation of Convertible Promissory Notes The Company evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion features of the convertible promissory notes were not afforded the exemption for conventional convertible instruments due to variable conversion rates. The notes have no explicit limit on the number of shares issuable, so they did not meet the conditions set forth for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivatives. The derivative liability is adjusted periodically according to the stock price fluctuations. Derivative Liability The derivative liability recognized in the financial statements for the convertible promissory notes as of June 30 31, 2024 was $14,101,479. WODI During the six months ended June 30, 2024, WODI raised capital in the amount of $2,042,500 by issuing convertible secured promissory notes to investors, bearing interest at a rate of 10% interest per annum. Additionally, during the period ended June 30, 2024, as part of settlement, conversion and redemption agreements with WODI shareholders, an aggregate of 139,560,037 shares of the Parent Company’s common stock were redeemed at the closing share prices on the dates of the convertible secured promissory note agreements. This fair value of redeemed common stock was added to the cash value of the shareholders’ investments to purchase WODI convertible secured promissory notes. The loss relating to these settlement and conversion agreements, amounting to $

Revenue from Contracts with Cus

Revenue from Contracts with Customers	6 Months Ended
	Jun. 30, 2024
Revenue from Contracts with Customers [Abstract]
Revenue from Contracts with Customers	7. Revenue from Contracts with Customers Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations are satisfied over time in accordance with ASC 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, if a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table present the Company’s revenues disaggregated by revenue sources:. Six Months Ended June 30, 2024 2023 Equipment Contracts $ 1,167,482 $ 1,980,345 Component Sales 715,977 378,872 Pump Stations 487,791 305,712 Waste Water Treatment Systems 134,262 1,124,075 Services Sales 72,184 33,015 Commission & Training 26,500 1,913 Rental Income 6,573 13,146 $ 2,610,769 $ 3,837,078 Aggregate revenue of $6,573 and $13,146 from continued operations for the six months ended June 30, 2024 and 2023, respectively, and aggregate revenue from discontinued operations was $2,604,196 and $3,823,932 for the six months ended June 30, 2024 and 2023, respectively. Revenue recognition for other sales arrangements, such as sales for components, and service sales will remain materially consistent. Contract assets represent revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represent billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying condensed consolidated balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the six months ended June 30, 2024 and the year ended December 31, 2023, was $476,906 and $445,102, respectively. The contract liability for the six months ended June 30, 2024, and the year ended December 31, 2023, was $1,619,759 and $1,346,366, respectively.

Financial Assets

Financial Assets	6 Months Ended
	Jun. 30, 2024
Financial Assets [Abstract]
Financial Assets	8. Financial Assets Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc.’s technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into 1,000 shares of WTII common stock. The stock was valued at fair market value of $0.0075 per share, totaling $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. This functionality does not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the condensed consolidated financial statements as of June 30, 2018. As of June 30, 2024, the fair value of the preferred shares was $3,200, with no loss in fair value. On November 12, 2021, the Company served a conversion notice to WTII and was issued an aggregate of 45,208,649 shares of WTII common stock. As of June 30, 2024, the investment in securities was recorded at fair value in the amount of $36,167.

Loans Payable

Loans Payable	6 Months Ended
	Jun. 30, 2024
Loans Payable [Abstract]
Loans Payable	9. Loans Payable Secured Loans Payable In 2018, the Company entered into short-term loans with various lenders for capital expansion, secured by the Company’s assets, in the amount of $1,749,970, which included finance cost of $624,810. The finance costs were amortized over the terms of the loans, which had various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. The term of the loans ranged from two months to six months. The net balance as of June 30, 2024 was $0. On December 6, 2023, the Company entered into short-term loan arrangement with a lender, secured by the Company’s assets, in the amount of $149,900, which included finance cost of $59,900. These finance costs were expensed upon initiation of the loan, resulting in a net amount of $90,000 received by the Company. The loan was fully paid off during the six months ended June 30, 2024 and as of June 30, 2024, the balance outstanding is $0. Settlement of Liability with C6 Capital LLC On March 12, 2021, the Company, through it’s subsidiary PWT entered into a settlement agreement with C6 Capital LLC to resolve a dispute regarding merchant cash agreement. As part of the settlement, C6 Capital vacated the judgment against the company, released all encumbrances, and the Company was released from any further amounts owed to C6 Capital. As a result, the Company recognized a gain of $30,646 during the six months ended June 30,2024, related to the write-off of the remaining liability attributed to C6 Capital. This gain is reflected in the consolidated statement of cash flows, Gain on the extinguishment of debt. Small Business Administration Loan On June 12, 2020, the Company received an Economic Injury Disaster Loan (the “EIDL”) in the amount of $150,000. Following the deferral period for the EIDL, the Company started to repay the principal amount, with interest, on a monthly basis. As of June 30, 2024, the remaining balance on the EIDL was $145,890. Receivables Financing Agreement On May 13, 2024, the Company entered into a Future Receivables Agreement with Lee Advance LLC. Under this agreement, the Company received $150,000 in exchange for selling 11% of its future receivables until a total of $225,000 is repaid. The agreement grants Lee Advance LLC a security interest in all of the Company’s assets, including accounts, equipment and inventory. The origination fee for this agreement was $15,000 and the payments are made weekly, based on a specified percentage of daily receipts. As of June 30, 2024, the balance outstanding under this arrangement is $145,250. In addition to the origination fee, the financing arrangement includes an additional $75,000 recognized as debt discount. This $90,000 is recognized as an interest expense and amortized over the term of the agreement. This amortization is reflected in the consolidated statement of cash flows under Debt discount recognized as interest expense.

WODI

WODI	6 Months Ended
	Jun. 30, 2024
WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations [Abstract]
WODI	10. WODI WODI was incorporated in the state of Nevada on April 22, 2022. WODI, with the support of its parent, the Company, is developing a new outsourced water treatment business called WOD. The WOD model intends to offer private businesses the ability to pay for water treatment and purification services on a per-gallon basis, commonly known as DBOO. WODI intends to work with regional water service companies to build and operate the water treatment systems it finances. On November 16, 2022, WODI filed a Form 1-A Offering Circular for an offering under Regulation A (the “WODI Reg A Offering”) of the Securities Act of 1933 with the U.S. Securities and Exchange Commission. The purpose of the WODI Reg A Offering is to allow potential investors the opportunity to invest directly in WODI. The Offering had a minimum investment of $1,000 per investor and was conducted on a best-efforts basis. An aggregate of 12,000 shares were sold for total proceeds of $60,000 under the WODI Reg A Offering. The WODI Reg A Offering was suspended in June 2023. On December 22, 2022, WODI entered into a Membership Interest Purchase and Transfer Agreement (the “Purchase Agreement”) with Ka Wai Cheung, Koon Lin Chan, and Koon Keung Chan (each a “Seller”, and collectively, the “Sellers”) and Fortune Rise Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which WODI purchased 100 membership interests in the Sponsor (“Purchased Interests”) from the Sellers, which constitutes 100% of the membership interests in the Sponsor. The Sponsor owns 2,343,750 shares out of 2,443,750 shares of the issued and outstanding shares of Class B common stock (the “Class B Common Stock”) of FRLA. On December 29, 2022, the Company announced that its subsidiary, WODI had closed its acquisition of Fortune Rise Sponsor, LLC, which is the sponsor of FRLA. On December 22, 2022, WODI paid a total of $1,137,267 to the Sellers of Fortune Rise Sponsor, LLC which included a total of $400,000 to purchase the membership interest in Class B Common Stock of FRLA and $737,267 for compensating the payment made by the Sellers on November 4, 2022, towards the first extension of the SPAC through February 5, 2023. In connection with the Extension Payment, FRLA issued unsecured promissory notes to the Sellers. As of December 31, 2022, the $737,267 amount was reflected as Notes Payable to related party on the consolidated balance sheet of the SPAC. To acquire the equity interests in FRLA for the purchase price of $400,000, WODI issued convertible secured promissory notes to investors at 10% interest per annum. Per the terms and conditions of the convertible promissory note, all unpaid principal, together with any unpaid and accrued interest shall be due and payable on the earlier of the twelve (12) month of the date of the Note (the “Maturity Date”) (provided, WODI shall have the option to extend the Maturity Date for up to two (2) six-month extensions), or (ii) when, upon the occurrence and during the continuance of an Event of Default. FRLA is a blank check company incorporated in February 2021 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. FRLA is a “shell company” as defined under the Exchange Act of 1934, as amended, because it has no operations and nominal assets consisting almost entirely of cash. The SPAC will not generate any operating revenues until after the completion of its initial business combination, at the earliest. On January 5, 2023, WODI signed a non-binding LOI with FRLA, (“FRLA” collectively with WODI, the “Parties”). The LOI is not binding on the Parties and is intended solely to guide good-faith negotiations toward a definitive business combination agreement. The Parties will work together in good faith with their respective advisors to agree on a structure for the business combination that is most expedient to the consummation of the acquisition, which may result in a new (merged) entity. Pursuant to the LOI, if a business combination were to be consummated and approved, all of the outstanding equity securities of WODI, including all shares of common stock, preferred stock, outstanding options and warrants will convert into new equity of the merged entity. On February 7, 2023, FRLA and OriginClear Inc. announced that WODI deposited $977,500 (the “Second Extension Payment”) into FRLA’s trust account for its public shareholders, representing $0.10 per public share, which enables FRLA to extend the period of time it has to consummate its initial business combination by an additional three months from February 5, 2023 to May 5, 2023 (the “Second Extension”). WODI assumed the obligation to make any necessary extension payments in connection with the extension of the period of time in which the SPAC may consummate its initial business combination as described in the SPAC’s S-1 Registration Statement, including the three-month extension from November 5, 2022 to February 5, 2023, the Second Extension for an additional three months from February 5, 2023 to May 5, 2023 and a final extension for an additional six months from May 5, 2023 to November 5, 2023. On April 10, 2023, at the Special Meeting, a total of 10,514,410 (or 81.61%) of FRLA’s issued and outstanding shares of Class A common stock and Class B common stock held of record as of March 3, 2023, were present either in person or by proxy, which constituted a quorum. In that FRLA shareholders agreed to an extension of the period of time it has to consummate its initial business combination by an additional six months from May 5, 2023 to November 5, 2023. FRLA’s stockholders voted on to approve and adopt the extension amendment which received sufficient votes (more than 65%) for approval. On April 14, 2023, WODI entered into an Asset Purchase Agreement with the Company, whereby it agreed to purchase all of the assets related to the Company’s “Modular Water Service” business, including licenses, technology, intellectual property, contracts, business models, patents and other assets in exchange for 6,000,000 shares of WODI common stock. The assets included MWS accounts receivables and accounts payables as of April 14, 2023 and an assignment of the Company’s existing global master license to the patents of inventor Daniel M. Early, P.E., who heads MWS, and the right to file patents for all additional inventions since 2018, when OriginClear created the MWS unit. Beginning on the Effective Date, all MWS transactions including revenue, accounts payable and accounts receivable were transferred from the Company’s PWT subsidiary over to the Company’s WODI subsidiary. On September 21, 2023, WODI entered into a merger agreement with PWT to create better enterprise value for a potential merger opportunity with FRLA and a plan of merger agreement (the “PWT-WODI merger agreement”) was entered into between WODI and PWT. Per the PWT-WODI merger agreement, all shares of WODI common and preferred stock were exchanged for shares of PWT common stock as merger consideration. WODI convertible notes and WODI Restricted Stock Grants were assumed by PWT and remain outstanding. WODI Series A and Series B were converted to WODI common stock prior to the merger. In connection with the merger with WODI, PWT changed its name to Water on Demand, Inc. Before issuing common stock to WODI stockholders in the PWT Merger, PWT had 10,000,000 common shares issued and outstanding, which were fully owned by OCLN. Post PWT-WODI merger, OCLN received an aggregate of 2,171,068 shares of WODI. On September 28, 2023, the LOI executed on January 5, 2023 with WODI was amended to designate PWT as the new target of the acquisition. Under the amended LOI, FRLA proposed to acquire all the outstanding securities of the new combined WODI/PWT entity, based on certain material financial and business terms and conditions being met. The LOI is not binding on the parties and is intended solely to guide good-faith negotiations toward definitive agreements. On October 24, 2023 FRLA and WODI entered into a definitive business combination agreement (the “BCA”). On October 25, 2023, at the Special Meeting, a total of 5,687,847 (or 84.59%) of FRLA’s issued and outstanding shares of Class A common stock and Class B common stock held of record, were present either in person or by proxy, which constituted a quorum. FRLA shareholders approved a proposal to extend the period of time FRLA has to consummate its initial business combination by an additional one year from November 5, 2023 to November 5, 2024, by up to twelve one-month extensions, subject to certain conditions. Promissory Notes Since acquiring the sponsorship interest in the SPAC on December 22, 2022, through June 30, 2024, WODI and the Company made payments on behalf of the SPAC in the aggregate amount of $5,051,985. As of June 30, 2024, WODI and the Company received an agg y notes (the “SPAC Notes”) from the SPAC in exchange for the payments made on behalf of the SPAC to meet its operating expenses and the extension payments. The SPAC Notes are non-interest bearing and payable (subject to the waiver against SPAC trust provisions) on the earlier of (i) consummation of the SPAC initial business combination; or (ii) the date of the liquidation of the SPAC. The principal balance of each SPAC Note may be prepaid at any time, at the election of the SPAC. As of the date of this filing, the SPAC has been extended through November 5, 2024, to give the Company adequate time to complete all the necessary administrative and regulatory steps, including filing of the registration statement and timely respond to satisfy potential comments, from regulatory bodies to consummate the business combination. Management estimates the likelihood of completing the business combination at 75%. Impairment of receivable Although the payments made on behalf of the SPAC are amounts receivable to WODI, for the period ended June 30, 2024, WODI considered the aggregate amount of $1,128,000 for the SPAC Notes to be impaired and recorded it as an expense on the consolidated income statements, as it is deemed probable that the SPAC may not have funds to pay back with interest all of the Class A shareholders and WODI for the amounts advanced to the SPAC. In the event of WODI successfully merging with the SPAC, all amounts paid by WODI on behalf of the SPAC, including any future payments made until such merger is fully consummated will be received back by WODI. Recording of membership interest As of June 30, 2024, WODI recorded the purchase of Class B Founder Shares at lower of cost or market at $400,000 on the condensed consolidated balance sheet as other asset held-for-sale. Impairment analysis for Class B Common Founder Shares as of June 30, 2024 The Company retained an independent valuation firm for the purpose of conducting a valuation of the fair value of Sponsor Founder Shares (Class B) of FRLA as of December 31, 2023. The independent firm (i) evaluated and analyzed various Sponsor Founder Shares of FRLA; (ii) assessed the terms including various redemption and liquidation features considering each of the Company’s financial plans and market conditions; and (iii) determined the underlying value to be assigned to the FRLA Sponsor Founder Shares as of the Date of Valuation and evaluated the FRLA Sponsor Founder Shares for impairment by performing the following procedures: ● Analyzed the Company’s S-4 filing, business combination agreement and other documentation. ● Developed Monte Carlo Model that values the FRLA Sponsor Founder Shares based on a multipath random event model and future projections of the various potential outcomes. The Monte Carlo Model simulation included 50,000 iterations and simulated the stock price, the timing of the business combination, and the timing of the lapse of the transfer restrictions. ● Developed the discounted cash flow from the sale of the securities at the time the restrictions terminated. ● Probability weighted the cash flow, discounted for lack of marketability. ● Valued the FRLA Sponsor Founder Shares as of the date of valuation. Based on the procedures performed the independent valuation firm concluded that the value of FRLA Sponsor Founder Shares was not impaired. Restricted Stock to WODI Board, Employees and Consultants Between August 12, 2022, and August 3, 2023, WODI entered into Restricted Stock Grant Agreements (the “WODI RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of WODI and to increase its value. WODI RSGAs provide for the issuance of up to 15,550,000 shares of WODI common stock provided certain milestones and vesting are met in certain stages. The restricted shares may become fully vested and no longer subject to risk of forfeiture (“Vested Shares”) if WODI shares are uplisted to a National Exchange, then upon such uplisting, 25% of the restricted shares that shall vest and become Vested Shares and 6.25% each three-month period thereafter, subject to the following: (i) If WODI shares are traded on a National Exchange, then the amount of restricted shares which shall become Vested Shares during any three-month period shall not exceed an amount representing the greater of (a) 1% of the shares of common stock outstanding as shown by the most recent SEC Report published by WODI and (b) the average weekly reported volume of trading in the common stock on a national securities exchange during the previous four calendar weeks. (ii) If WODI shares are subsequently delisted and quoted on the over-the-counter market, including the OTCQB, then the amount of restricted shares which shall become Vested Shares during any three month period shall not exceed an amount representing 1% of the shares of common stock outstanding as shown by the most recent SEC Report published by WODI, or if WODI shares are traded on a national securities exchange, the greater of (b)(i) and the average weekly reported volume of trading in the common stock on a national securities exchange during the previous four calendar weeks. If WODI shares do not achieve listing on a national securities exchange within three years of the Effective Date, then the restricted shares shall vest and become Vested Shares at a rate equal to 25% on the three-year anniversary of the Effective Date and 6.25% each three-month period thereafter. WODI has not recognized any costs associated the WODI RSGAs because milestones and vesting have not been achieved. As the milestones are achieved, the shares shall become eligible for vesting and issuance. On September 21, 2023, per the Merger Plan Agreement and per the conversion ratio of 0.19737 established in the Merger Plan Agreement, the 15,550,000 total issuable shares under the WODI RSGAs were converted to 3,069,100 total issuable shares. On October 23, 2023, certain WODI RSGAs were canceled and new WODI RSGAs were issued. As of June 30, 2024, there were 2,581,344 total issuable shares under the WODI RSGAs. As the milestones are achieved, the shares shall become eligible for vesting and issuance. During the six months ended June 30, 2024, no issuable shares under the WODI RSGAs vested and no costs associated with the milestones were recognized because achievement is not probable.

Line of Credit

Line of Credit	6 Months Ended
	Jun. 30, 2024
Line of Credit [Abstract]
LINE OF CREDIT	11. Line of Credit During the year ended December 31, 2023, the Company obtained 12-month credit lines in the aggregate amount of $345,875, with an interest rate of 26.07%. Through June 30, 2024, the Company paid principal in the amount of $292,812, leaving a principal balance of $53,063 as of June 30, 2024.

Assets Held for Sale _ Continui

Assets Held for Sale – Continuing Operations	6 Months Ended
	Jun. 30, 2024
Assets Held for Sale – Continuing Operations [Abstract]
Assets Held for Sale – Continuing Operations	12. Assets Held for Sale – Continuing Operations On March 1, 2021, the Company issued an aggregate of 630 shares of Series T preferred stock to the Purchaser per terms of a SPA. According to the SPA, the Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T preferred stock, along with two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share. These warrants were exercisable at any time, in whole or in part. In lieu of the purchase price for the Series T preferred stock, the Purchaser transferred to the Company real property in Buenos Aires, Argentina, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company at that time. The real property was recorded at $630,000 upon exchange for the 630 shares of Series T preferred stock. Based on indicators of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the asset held for sale from $630,000 to $514,000 and recorded an impairment of $116,000 in the consolidated financial statements. During the period ended December 31, 2022, after evaluating several offers, the Company considered an offer for $400,000, which was $114,000 below the previously adjusted value and was indicative of the real estate market conditions in Buenos Aires, Argentina. Based on this indicator of impairment, the Company further adjusted the value of the assets held for sale from $514,000 to $400,000 on the condensed balance sheet and recorded an additional impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted, and the warrants associated with the Series T expired during the period ended December 31, 2022. In January 2023, the Company accepted the offer, and on April 8, 2023, a deed was executed for the sale of the property for $400,000. The agreed upon payment terms were an initial payment of $235,000, with the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each. The initial payment was received by SMS , an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the property. From the proceeds, SMS remitted taxes due on the transaction to the AFIP, which administers taxation in Argentina. On June 21, 2023, the Company received a payment of $164,935, net of all taxes assessed by AFIP and other closing fees associated with the sale of the property totaling $65,493 and recorded a receivable of $169,572 for the remaining balance. As of June 30, 2024, the balance of the receivable was $33,000 which is reflected on the consolidated financial statements.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies [Abstract]
Commitments and Contingencies	13. Commitments and Contingencies Facility Rental – Related Party Our Dallas based subsidiary, PWT, rents an approximately 12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a current monthly rent of $8,500. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company maintains various insurance policies relating to the guarantee of completed work, which, in the opinion of management, will adequately cover any potential claims. A warranty reserve has been established based on management’s assessment and Company history in the amount of $20,000 for six months ended June 30, 2024 and the year ending December 31, 2023. Litigation There are no material updates to the litigation matters with Process Solutions, Inc. as previously disclosed in the Form 10-K filed on April 18, 2024.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events Management has evaluated subsequent events in accordance with ASC Topic 855 and has identified the following subsequent events: OCLN Preferred Stock Conversions ● On July 12, 2024, July 24, 2024, and August 1, 2024, holders converted a total of 0.82 Series Y shares into 18,927,182 common shares at conversion prices ranging from $0.0068 to $0.0071 per share. OCLN Stock Cancellations by WODI Notes: ● On July 3, 2024, July 12, 2024, July 24, 2024, August 1, 2024, and August 7, 2024, a total of 52,271,686 common shares of OCLN stock were redeemed and canceled per WODI Notes, which the value applied as credits to the respective notes. Shares issued for services ● On July 1, 2024, July 15, 2024, and July 31, 2024, a total of 5,788,449 common shares of OCLN stock were issued for consulting and advisory services in connection with various agreements. Series Y Shares ● Between July 1, 2024 and August 12, 2024, the company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 3.25 shares of the Company’s series Y preferred stock for an aggregate purchase price of $325,000. The Company also issued an aggregate of 2,600,000 warrants to purchase common shares to its investors.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 3,607,348	$ (7,684,843)	$ (12,288,935)	$ (4,602,808)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its subsidiaries: WODI, (which consists of operating divisions Progressive Water Treatment, Modular Water Systems and Water On Demand), Water On Demand #1, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to, impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share is calculated by dividing net income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated similarly to basic earnings per share, except that the denominator is adjusted to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. For the six months ended June 30, 2024, and 2023, the Company’s diluted earnings per share were the same as basic loss per share because the inclusion of any potential common shares would have been anti-dilutive due to the Company’s net losses. The Company excludes issuable shares from warrants, convertible notes, and preferred stock, if their impact on the loss per share is anti-dilutive, and includes the issuable shares if their impact is dilutive. Loss per share For the Six Months Ended June 30, 2024 2023 Loss to common shareholders (Numerator)- continuing operations $ (8,423,246 ) $ 4,668,738 Loss to common shareholders (Numerator) - related to assets held-for-sale (3,865,689 ) (9,271,546 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 1,501,184,304 1,243,518,367 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue in accordance with Accounting Standards Codification (“ASC”) ASC 606, Revenue from Contract with Customers (“ASC 606”). We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.
Nature of Contracts and Performance Obligations	Nature of Contracts and Performance Obligations Engineered Water Treatment Solutions (PWT) We design, manufacture, and install our customer water treatment systems for municipalities, industrial clients, and commercial entities. Our performance obligations typically include the delivery and installation of water treatment systems that meet specific customer requirements. Revenue from these contracts is recognized over time as performance obligations are satisfied, using a cost-cost input method, which reflects the extent of progress towards completion. The transaction price is determined based on fixed fees agreed upon in the contract, and any variable considerations, such as performance bonuses, are estimated at contract inception and constrained to avoid significant reversals. Sales Price Calculation The transaction price for each contract is determined based on the agreed-upon terms with the customer, indicating fixed fees and variable consideration where applicable. Variable consideration is estimated at contract inception and constrained to the extent that is it probable that significant reversal of recognized revenue will not occur when the uncertainty is resolved. Contract Modifications Contract modifications are accounted for when they create or change existing enforceable rights and obligations. The impact of modifications on transaction prices and performance obligations is recognized in the period when the modifications are approved. Significant Judgements and Estimates ● Estimating Progress Towards Completion: For long-term contracts, we use the cost-to-cost method to estimate progress towards completion, considering total costs incurred relative to total estimated costs to complete the project. ● Variable Consideration: Estimates to variable considerations are constrained to ensure that recognized revenue is not subject to significant reversals in future periods. Material Rights and Obligations Our contracts may include material rights for customers to receive effective water treatment solutions and ongoing maintenance services. Our obligations include designing, manufacturing, delivering, installing, and maintaining water treatment systems, as well as providing continuous water treatment services under the DBOO model. In accordance with ASC 280-10-50-38 through 50-41, we provide entity wide disclosures, including: ● Product and Services: Our products and service offering include comprehensive water treatment solutions, such as design, manufacturing, and outsourced water treatment services. ● Geographical Areas: We primarily serve customers in the United States and Canada, with some international clients in Japan, Argentina and the Middle East. Significant Customers Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions are estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based on progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations and not allocated to contract costs. We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with ASC 606. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements, which generally require billing on a progressive basis as work is completed. Credit is extended based on evaluation of each client’s financial condition, and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of past-due receivables from customers on a monthly basis. An allowance against uncollectible items is recorded for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. Reasonable means of collection may include multiple follow-up communications, renegotiation of payment terms, and if necessary, legal action. The allowance for doubtful accounts was $355,453 and $379,335 as of June 30, 2024, and December 31, 2023, respectively. The net contract receivable balance was $1,247,416 and $1,509,504 as of June 30, 2024, and December 31, 2023, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations.” Under this method, total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price allocation uses the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed, is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year, or whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill as of June 30, 2024, and 2023, respectively, and determined there was no impairment of indefinite lived intangibles and goodwill.
Prepaid Expenses	Prepaid Expenses The Company records expenditures that have been paid in advance for goods or services to be received in the future as prepaid expenses. These prepaid expenses are initially recorded as assets because they have future economic benefits. They are expensed as the benefits are realized. The prepaid expenses balance was $45,401 and $0 as of June 30, 2024, and December 31, 2023, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and improvement are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 3-7 years Computer software 3 years Vehicles 3-6 years Leasehold improvements 2-5 years or lease term June 30, December 31, 2024 2023 Machinery and equipment $ 383,571 $ 383,569 Computer equipment and software 66,491 66,493 Vehicles 64,277 64,276 Demo Units 36,139 36,139 Furniture and fixtures 29,809 29,810 Leasehold improvements 26,725 26,725 Gross property and equipment 607,012 607,012 Less accumulated depreciation (474,774 ) (460,276 ) Net property and equipment $ 132,238 $ 146,736 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the event that the facts and circumstances indicate that the cost of any long-lived assets be impaired, an evaluation of recoverability would be performed in accordance with GAAP. Depreciation expense during the six months ended June 30, 2024, and 2023, was $14,498 and $15,432, respectively.
Long Term Asset Held for Sale	Long Term Asset Held for Sale On March 1, 2021, the Company issued 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per the terms of a Securities Purchase Agreement (the “SPA”). According to the SPA, the Purchaser received 630 shares of Series T Preferred Stock, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share. These warrants are exercisable at any time, in whole or in part. In lieu of the purchase price for the Series T Preferred Stock, the Purchaser transferred to the Company real property with an aggregate value of $630,000. This property, based on a independent appraisal, consisted of residential real estate in Buenos Aires, Argentina, valued at $580,000, and eight undeveloped lots in the Terralta private neighborhood development, valued at $50,000. The property was recorded on the condensed consolidated balance sheet as long-term asset held for sale at $630,000. The property was listed for sale in July 2021. Due to impairment indicators during the year ended December 31, 2021, the Company reduced the value of the asset from $630,000 to $514,000, recording an impairment of $116,000 in the consolidated financial statements. During the year ended December 31, 2022, after evaluating several offers, the Company accepted an offer of $400,000, which was $114,000 below the adjusted value, reflecting the real estate market conditions in Buenos Aires, Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the value of the asset held for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted, and the related warrants expired by during the period ended December 31, 2022. In January 2023, the Company accepted the offer and on April 8, 2023, executed a deed for the sale of the property for $400,000. The payment terms included an initial payment of $235,000, with the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each. The initial payment was received by SMS Argentina (“SMS”), an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the property. SMS remitted taxes due on the transaction to the Federal Administration of Public Income (“AFIP”), the taxation authority in Argentina. On June 21, 2023, the Company received a net payment of $164,935, after taxes and closing fees totaling $65,493. During 2023, the Company recorded a receivable of $169,572 for the remaining amount on the consolidated financial statements. As of June 30, 2024, the balance of the receivable was $33,000 which is reflected on the condensed consolidated balance sheet.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board (“FASB”), where the value of the award is measured on the grant date and recognized over the vesting period. For stock option and warrant grants issued and vesting to non-employees, the Company follows the authoritative guidance of the FASB, where the value of the stock compensation is determined based upon the measurement date, which is either (a) the date at which a performance commitment is reached, or (b) the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges are generally amortized over the vesting period on a straight-line basis. If there are no future performance requirements by the non-employee, option grants vest immediately, and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all its financial instruments to determine if they qualify as derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments accounted for as liabilities, the derivative instrument is initially recorded at its fair value and revalued at each reporting date. Changes in the fair value are reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a probability-weighted average series Binomial lattice option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including the determination of whether they should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified on the condensed consolidated balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the condensed consolidated balance sheet, where it is practicable to estimate that value. As of June 30, 2024, the balances reported for cash, contract receivables, costs in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value due to their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1: Observable inputs such as quoted prices for identical instruments in active markets; ● Level 2: Inputs other than quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active. ● Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of June 30, 2024: Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, June 30, 2024 $ 39,367 $ 39,367 $ - $ - Total (Level 1) (Level 2) (Level 3) Convertible notes liability $ 14,101,479 $ - $ - $ 14,101,479 Warrants liability 234,791 - - 234,791 Total derivative liability, June 30, 2024 14,336,270 - - 14,336,270 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2024 $ 7,742,759 Net loss on conversion of debt and change in derivative liabilities 6,593,511 Balance as of June 30, 2024 $ 14,336,270 For the purpose of determining the fair market value of the derivative liability, the Company used a Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: June 30, 2024 Risk free interest rate 4.53% - 5.01% Stock volatility factor 101.9% - 218.8% Weighted average expected option life (in years) .5 - 4.5 Expected dividend yield None
Segment Reporting	Segment Reporting The Company operates in a single business segment based on its organizational structure and the manner in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments, except those accounted for under the equity method of accounting, or those that result in consolidation of the investee, to be measured at fair value, with changes in fair value recognized in net income. It also mandates the use the exit price notion for measuring the fair value of financial instruments for disclosure purposes and requires the separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. Additionally, it eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value of financial instruments measured at amortized cost. The Company evaluated the impact of this standard on the condensed consolidated financial statements and determined it had a significant impact. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, with unrealized gains on these securities recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of intellectual property (“IP”) is distinct from the non-license goods or services and possesses significant standalone functionality that provides a benefit or value to the customer. This functionality does not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, revenue is generally recognized when the license is delivered.
Reclassification	Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation used in the current condensed consolidated financial statements for comparative purposes. These reclassifications had no material effect on the Company’s previously issued financial statements.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work-in-process includes the cost of materials and labor related to the construction of equipment to be sold to customers.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management has reviewed recently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Schedule of Issuable Shares from Warrants, Convertible Notes, and Preferred Stock if their Impact on the Loss Per Share is Anti-Dilutive	The Company excludes issuable shares from warrants, convertible notes, and preferred stock, if their impact on the loss per share is anti-dilutive, and includes the issuable shares if their impact is dilutive. For the Six Months Ended June 30, 2024 2023 Loss to common shareholders (Numerator)- continuing operations $ (8,423,246 ) $ 4,668,738 Loss to common shareholders (Numerator) - related to assets held-for-sale (3,865,689 ) (9,271,546 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 1,501,184,304 1,243,518,367
Schedule of Furniture and Equipment Estimated Useful Lives	Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 3-7 years Computer software 3 years Vehicles 3-6 years Leasehold improvements 2-5 years or lease term
Schedule of Property Plant and Equipment	June 30, December 31, 2024 2023 Machinery and equipment $ 383,571 $ 383,569 Computer equipment and software 66,491 66,493 Vehicles 64,277 64,276 Demo Units 36,139 36,139 Furniture and fixtures 29,809 29,810 Leasehold improvements 26,725 26,725 Gross property and equipment 607,012 607,012 Less accumulated depreciation (474,774 ) (460,276 ) Net property and equipment $ 132,238 $ 146,736
Schedule of Financial Assets Measured and Recorded at Fair Value on a Recurring Basis	The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of June 30, 2024: Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, June 30, 2024 $ 39,367 $ 39,367 $ - $ - Total (Level 1) (Level 2) (Level 3) Convertible notes liability $ 14,101,479 $ - $ - $ 14,101,479 Warrants liability 234,791 - - 234,791 Total derivative liability, June 30, 2024 14,336,270 - - 14,336,270
Schedule of Reconciliation of the Derivative Liability for which Level 3 Inputs	The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2024 $ 7,742,759 Net loss on conversion of debt and change in derivative liabilities 6,593,511 Balance as of June 30, 2024 $ 14,336,270
Schedule of Fair Market Value of the Derivative Liability	For the purpose of determining the fair market value of the derivative liability, the Company used a Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: June 30, 2024 Risk free interest rate 4.53% - 5.01% Stock volatility factor 101.9% - 218.8% Weighted average expected option life (in years) .5 - 4.5 Expected dividend yield None

WODI Assets and Liabilities H_2

WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations (Tables)	6 Months Ended
	Jun. 30, 2024
WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations [Abstract]
Schedule of Assets and Liabilities Held-For-Sale	Assets and Liabilities Held-For-Sale June 30, December 31, 2024 2023 CURRENT ASSETS Cash $ 202,644 $ 374,192 Contracts receivable, net allowance of $355,453 and $379,335, respectively (Note 2) 1,247,416 1,509,504 Contract assets (Note 7) 476,906 455,102 Prepaid expenses 34,354 - Total Current Assets Held-For-Sale 1,961,320 2,338,798 NET PROPERTY AND EQUIPMENT HELD-FOR-SALE 2,006 3,370 NON-CURRENT ASSETS HELD-FOR SALE SPAC Class B common shares purchase cost (Note 10) 400,000 400,000 Security deposit 18,000 - 418,000 400,000 CURRENT LIABILITIES HELD-FOR-SALE Accounts payable and other payable $ 1,459,460 $ 1,335,211 Accrued expenses 1,992,046 1,103,159 Contract liabilities (Note 7) 1,619,759 1,346,366 Tax liability 83(b) 13,600 13,600 Customer deposit 143,503 143,503 Warranty reserve 20,000 20,000 Line of credit (Note 11) 53,063 178,808 Secured loans payable 146,250 110,695 Convertible secured promissory notes (Note 6) 20,068,589 16,729,089 Total Current Liabilities Held-For-Sale $ 25,516,270 $ 20,980,431 Six Months Ended 2024 2023 Sales $ 2,604,196 $ 3,823,932 Cost of goods sold 2,332,346 3,513,086 Gross Profit 271,850 310,846 Operating Expenses Selling and marketing expenses 94,671 42,988 General and administrative expenses 578,784 560,247 Total Operating Expenses 673,455 603,235 Loss from Operations (401,605 ) (292,389 ) OTHER INCOME (EXPENSE) Other income 1,143 126,879 Impairment of receivable from SPAC (1,128,000 ) (2,600,985 ) Conversion and settlement value added to note purchase agreements (see Note 6) (1,297,000 ) (6,037,589 ) Preferred stock compensation expense - (155,852 ) Interest expense (1,040,227 ) (311,610 ) TOTAL OTHER (EXPENSE) INCOME (3,464,084 ) (8,979,157 ) NET LOSS FROM ASSETS-HELD-FOR-SALE $ (3,865,689 ) $ (9,271,546 )

Capital Stock (Tables)

Capital Stock (Tables)	6 Months Ended
	Jun. 30, 2024
Capital Stock [Abstract]
Schedule of Non-controlling Interest	The following table shows WODI ownership percentage as of June 30, 2024: WODI common stock holders Ownership OriginClear, Inc. 90.83 % Prior Reg A Holders 0.19 % Prior Series A Holders 3.87 % Prior Series B Holders 5.11 % Total 100 %

Restricted Stock Grants and W_2

Restricted Stock Grants and Warrants (Tables)	6 Months Ended
	Jun. 30, 2024
Restricted Stock Grants and Warrants [Abstract]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding	A summary of the Company’s warrant activity and related information for the six months ended June 30, 2024, is as follows: Weighted average Number of exercise Warrants price Outstanding - beginning of period 64,401,089 $ 0.1383 Granted 4,600,800 $ 0.1250 Exercised - $ - Expired (48,500 ) $ 1.0000 Outstanding - end of period 68,953,389 $ 0.1368
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding	At June 30, 2024, the weighted average remaining contractual life of warrants outstanding: Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.0200 600,000 600,000 2.17 $ 0.1000 2,500,000 2,500,000 6.91 $ 0.2500 3,760,000 3,760,000 2.64 $ 0.0275 8,727,273 8,727,273 3.20 $ 0.1250 51,854,616 51,854,616 2.47 $ 1.0000 1,511,500 1,511,500 0.23 68,953,389 68,953,389

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	6 Months Ended
	Jun. 30, 2024
Convertible Promissory Notes [Abstract]
Schedule of Outstanding Convertible Promissory Notes	As of June 30, 2024, the outstanding convertible promissory notes are summarized as follows: Convertible promissory notes $ 2,617,691 Less current portion 597,944 Total long-term liabilities $ 2,019,747
Schedule of Maturities of Long-Term Debt	Maturities of long-term debt for the next three years are as follows: Period ending June 30, Amount 2024 (remaining 6 months) - 2025 82,472 2026 1,875,000 2027 - 2028 62,275 $ 2,019,747

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	6 Months Ended
	Jun. 30, 2024
Revenue from Contracts with Customers [Abstract]
Schedule of Good or Service from Contracts with Customers	The following table present the Company’s revenues disaggregated by revenue sources:. Six Months Ended June 30, 2024 2023 Equipment Contracts $ 1,167,482 $ 1,980,345 Component Sales 715,977 378,872 Pump Stations 487,791 305,712 Waste Water Treatment Systems 134,262 1,124,075 Services Sales 72,184 33,015 Commission & Training 26,500 1,913 Rental Income 6,573 13,146 $ 2,610,769 $ 3,837,078

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Basis of Presentation [Abstract]
Revenue		$ 6,573	$ 6,573	$ 13,146

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)				1 Months Ended	6 Months Ended		12 Months Ended
	Jun. 21, 2023	Apr. 08, 2023	Mar. 01, 2021	Jul. 31, 2021	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	May 13, 2024	Dec. 31, 2023
Summary of Significant Accounting Polices [Line Items]
Allowance for doubtful accounts					$ 355,453					$ 379,335
Contract receivable					1,247,416					1,509,504
Prepaid expenses					45,401					$ 0
Depreciation expense					$ 14,498	$ 15,432
Acquire share (in Shares)			25,200,000
Common stock, per share (in Dollars per share)					$ 0.0001	$ 0.01				$ 0.0001
Transfer of property			$ 630,000
Real estate property value		$ 400,000	580,000
Private development			50,000
Assets held for sale					$ 418,000					$ 400,000
Asset for sale				$ 630,000			$ 514,000
Impairment of assets				116,000			114,000	$ 116,000
Initial payment		235,000
Monthly installments payment		$ 165,000
Fifteen monthly installments		15 months
Installment amount		$ 11,000
Additional payments amount	$ 164,935
Closing fees	$ 65,493
Recorded of receivable					$ 33,000	$ 169,572			$ 225,000
Minimum [Member]
Summary of Significant Accounting Polices [Line Items]
Asset for sale				$ 514,000			400,000	$ 514,000
Buenos Aires, Argentina [Member]
Summary of Significant Accounting Polices [Line Items]
Real estate property value							400,000
Assets held for sale			$ 630,000
Impairment of assets							114,000
Buenos Aires, Argentina [Member] | Minimum [Member]
Summary of Significant Accounting Polices [Line Items]
Asset for sale							$ 400,000
Series T Preferred Stock [Member]
Summary of Significant Accounting Polices [Line Items]
Issued an aggregate shares (in Shares)			630
Real property share (in Shares)			630
Series T Preferred Stock [Member] | Buenos Aires, Argentina [Member]
Summary of Significant Accounting Polices [Line Items]
Real property share (in Shares)			630
Common Stock [Member]
Summary of Significant Accounting Polices [Line Items]
Issued an aggregate shares (in Shares)					122,213,744
Common stock, per share (in Dollars per share)			$ 0.05		$ 0.01

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of Issuable Shares from Warrants, Convertible Notes, and Preferred Stock if their Impact on the Loss Per Share is Anti-Dilutive - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Schedule of Issuable Shares from Warrants, Convertible Notes, and Preferred Stock if their Impact on the Loss Per Share is Anti-Dilutive [Abstract]
Loss to common shareholders (Numerator)- continuing operations			$ (8,423,246)	$ 4,668,738
Loss to common shareholders (Numerator) - related to assets held-for-sale			$ (3,865,689)	$ (9,271,546)
Basic weighted average number of common shares outstanding (Denominator) (in Shares)	1,558,824,206	1,195,322,992	1,501,184,304	1,243,518,367

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of Issuable Shares from Warrants, Convertible Notes, and Preferred Stock if their Impact on the Loss Per Share is Anti-Dilutive (Parentheticals) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Schedule of Issuable Shares from Warrants, Convertible Notes, and Preferred Stock if their Impact on the Loss Per Share is Anti-Dilutive [Abstract]
Diluted weighted average number of common shares outstanding (Denominator)	1,558,824,206	1,195,322,992	1,501,184,304	1,243,518,367

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of Furniture and Equipment Estimated Useful Lives	Jun. 30, 2024
Computer software [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	3 years
Minimum [Member] | Machinery and equipment [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	5 years
Minimum [Member] | Furniture, fixtures and computer equipment [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	3 years
Minimum [Member] | Vehicles [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	3 years
Minimum [Member] | Leasehold improvements [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	2 years
Maximum [Member] | Machinery and equipment [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	10 years
Maximum [Member] | Furniture, fixtures and computer equipment [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	7 years
Maximum [Member] | Vehicles [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	6 years
Maximum [Member] | Leasehold improvements [Member]
Schedule of Furniture and Equipment Estimated Useful Lives [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details) - Schedule of Property Plant and Equipment - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	$ 607,012	$ 607,012
Less accumulated depreciation	(474,774)	(460,276)
Net property and equipment	132,238	146,736
Machinery and equipment [Member]
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	383,571	383,569
Computer equipment and software [Member]
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	66,491	66,493
Vehicles [Member]
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	64,277	64,276
Demo Units [Member]
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	36,139	36,139
Furniture and fixtures [Member]
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	29,809	29,810
Leasehold improvements [Member]
Schedule of Property Plant and Equipment [Line Items]
Gross property and equipment	$ 26,725	$ 26,725

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details) - Schedule of Financial Assets Measured and Recorded at Fair Value on a Recurring Basis - Fair Value, Recurring [Member]	Jun. 30, 2024 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities, June 30, 2024	$ 39,367
Convertible notes liability	14,101,479
Warrants liability	234,791
Total derivative liability, June 30, 2024	14,336,270
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities, June 30, 2024	39,367
Convertible notes liability
Warrants liability
Total derivative liability, June 30, 2024
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities, June 30, 2024
Convertible notes liability
Warrants liability
Total derivative liability, June 30, 2024
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities, June 30, 2024
Convertible notes liability	14,101,479
Warrants liability	234,791
Total derivative liability, June 30, 2024	$ 14,336,270

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details) - Schedule of Reconciliation of the Derivative Liability for which Level 3 Inputs	6 Months Ended
	Jun. 30, 2024 USD ($)
Schedule of Reconciliation of the Derivative Liability for Which Level 3 inputs [Abstract]
Balance as of January 1, 2024	$ 7,742,759
Net loss on conversion of debt and change in derivative liabilities	6,593,511
Balance as of June 30, 2024	$ 14,336,270

Summary of Significant Accou_10

Summary of Significant Accounting Policies (Details) - Schedule of Fair Market Value of the Derivative Liability	Jun. 30, 2024
Risk free interest rate [Member] | Minimum [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	4.53
Risk free interest rate [Member] | Maximum [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	5.01
Stock volatility factor [Member] | Minimum [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	101.9
Stock volatility factor [Member] | Maximum [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	218.8
Weighted average expected option life (in years) [Member] | Minimum [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	5
Weighted average expected option life (in years) [Member] | Maximum [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	4.5
Expected dividend yield [Member]
Schedule of Fair Market Value of the Derivative Liability [Line Items]
Fair market value of the derivative liability	0

WODI Assets and Liabilities H_3

WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations (Details) $ in Millions	Oct. 24, 2023 USD ($)
Water on Demand, Inc [Member]
Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations [Line Items]
Equity valuation	$ 72

WODI Assets and Liabilities H_4

WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations (Details) - Schedule of Assets and Liabilities Held-For-Sale - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Assets and Liabilities Held-For-Sale [Member]
CURRENT ASSETS
Cash	$ 202,644		$ 374,192
Contracts receivable, net allowance of $355,453 and $379,335, respectively (Note 2)	1,247,416		1,509,504
Contract assets (Note 7)	476,906		455,102
Prepaid expenses	34,354
Total Current Assets Held-For-Sale	1,961,320		2,338,798
NET PROPERTY AND EQUIPMENT HELD-FOR-SALE	2,006		3,370
NON-CURRENT ASSETS HELD-FOR SALE
SPAC Class B common shares purchase cost (Note 10)	400,000		400,000
Security deposit	18,000
NON-CURRENT ASSETS HELD-FOR SALE , Total	418,000		400,000
CURRENT LIABILITIES HELD-FOR-SALE
Accounts payable and other payable	1,459,460		1,335,211
Accrued expenses	1,992,046		1,103,159
Contract liabilities (Note 7)	1,619,759		1,346,366
Tax liability 83(b)	13,600		13,600
Customer deposit	143,503		143,503
Warranty reserve	20,000		20,000
Line of credit (Note 11)	53,063		178,808
Secured loans payable	146,250		110,695
Convertible secured promissory notes (Note 6)	20,068,589		16,729,089
Total Current Liabilities Held-For-Sale	25,516,270		$ 20,980,431
Net Loss from Assets-Held-For-Sale [Member]
CURRENT LIABILITIES HELD-FOR-SALE
Sales	2,604,196	$ 3,823,932
Cost of goods sold	2,332,346	3,513,086
Gross Profit	271,850	310,846
Operating Expenses
Selling and marketing expenses	94,671	42,988
General and administrative expenses	578,784	560,247
Total Operating Expenses	673,455	603,235
Loss from Operations	(401,605)	(292,389)
OTHER INCOME (EXPENSE)
Other income	1,143	126,879
Impairment of receivable from SPAC	(1,128,000)	(2,600,985)
Conversion and settlement value added to note purchase agreements (see Note 6)	(1,297,000)	(6,037,589)
Preferred stock compensation expense		(155,852)
Interest expense	(1,040,227)	(311,610)
TOTAL OTHER (EXPENSE) INCOME	(3,464,084)	(8,979,157)
NET LOSS FROM ASSETS-HELD-FOR-SALE	$ (3,865,689)	$ (9,271,546)

WODI Assets and Liabilities H_5

WODI Assets and Liabilities Held-for-Sale, Discontinuing Operations (Details) - Schedule of Assets and Liabilities Held-For-Sale (Parentheticals) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Assets and Liabilities Held-For-Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contracts receivable, net allowance	$ 355,453	$ 379,335

Capital Stock (Details) - Part-

Capital Stock (Details) - Part-1 - USD ($)				6 Months Ended
	Aug. 21, 2020	Aug. 14, 2018	Mar. 14, 2017	Jun. 30, 2024	Dec. 31, 2023	Apr. 13, 2018
Series C Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock per share (in Dollars per share)			$ 0.0001
Preferred stock voting, percentage			51%
Purchase price of the series C preferred stock (in Dollars per share)			$ 0.1
Total share purchase (in Dollars)			$ 1,000
Preferred stock, shares outstanding				1,000	1,000
Preferred stock, shares issued				1,000	1,000
Series C Preferred Stock [Member] | Director [Member]
Capital Stock [Line Items]
Aggregate shares of common stock			1,000
Preferred stock per share (in Dollars per share)			$ 0.0001
Series C Preferred Stock [Member] | Chief Executive Officer [Member]
Capital Stock [Line Items]
Preferred stock, shares outstanding				1,000
Series D Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares outstanding				31,500,000	315,000,000
Preferred stock, share authorized						50,000,000
Aggregate preferred stock, share issued						0.0005
Preferred stock, shares issued				31,500,000	315,000,000
Series D Preferred Stock [Member] | Minimum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding						4.99%
Series D Preferred Stock [Member] | Maximum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding						9.99%
Series F Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares outstanding				50	60
Preferred stock, share authorized		6,000
Preferred stock, shares issued				50	60
Preferred stock liquidation per share (in Dollars per share)		$ 1,000
Dividend rate, percentage		8%
Conversion of Stock, Shares Issued				10
Aggregate redemption price (in Dollars)				$ 50,000	$ 60,000
Series Q Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock per share (in Dollars per share)	$ 1,000
Preferred stock, shares outstanding				410
Preferred stock, share authorized	2,000
Aggregate preferred stock, share issued				4,576,458
Preferred stock, shares issued				410
Dividend rate, percentage	12%
Conversion of Stock, Shares Issued				20
Number of shares				10
Series Q Preferred Stock [Member] | Minimum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding	4.99%
Series Q Preferred Stock [Member] | Maximum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding	9.99%

Capital Stock (Details) - Par_2

Capital Stock (Details) - Part-2 - USD ($)	Apr. 03, 2019	Jan. 16, 2019	Jun. 30, 2024	Dec. 31, 2023
Series G Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized		6,000
Liquidation preference value (in Dollars)		$ 1,000
Dividend rate, percentage		8%
Divided closing price (in Dollars)			$ 500
Preferred stock, shares issued			25	25
Preferred stock, shares outstanding			25	25
Aggregate redemption price (in Dollars)			$ 25,000	$ 25,000
Series I Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized	4,000
Liquidation preference value (in Dollars)	$ 1,000
Dividend rate, percentage	8%
Preferred stock, shares issued			25
Preferred stock, shares outstanding			25
Aggregate redemption price (in Dollars)			$ 25,000

Capital Stock (Details) - Par_3

Capital Stock (Details) - Part-3 - USD ($)					6 Months Ended
	Apr. 28, 2021	Jul. 01, 2020	Apr. 27, 2020	Jun. 03, 2019	Jun. 30, 2024	Dec. 31, 2023	Apr. 03, 2019
Capital Stock [Line Items]
Preferred stock, share authorized					600,000,000	600,000,000
Preferred stock per share (in Dollars per share)					$ 0.0001	$ 0.0001
Dividend rate, percentage			4%
Aggregate of shares					1,613,089,087	1,399,782,046
Series J Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized							100,000
Preferred stock per share (in Dollars per share)							$ 1,000
Preferred stock, shares issued					210
Preferred stock, shares outstanding					210
Series K Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized				4,000
Preferred stock per share (in Dollars per share)				$ 1,000
Preferred stock, shares issued					297.15
Preferred stock, shares outstanding					297.15
Dividend rate, percentage				8%
Aggregate preferred stock, share issued					10
Aggregate redemption price (in Dollars)					$ 297,150
Series W Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized	3,390
Preferred stock per share (in Dollars per share)	$ 1,000
Preferred stock, shares issued					696.5
Preferred stock, shares outstanding					696.5
Dividend rate, percentage	12%
Aggregate preferred stock, share issued					200
Aggregate shares of common stock					10
Conversion of Stock, Shares Issued					41,715,134
Series L Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized				100,000
Preferred stock per share (in Dollars per share)				$ 1,000
Preferred stock, shares issued					320.5
Preferred stock, shares outstanding					320.5
Series M Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized		800,000
Preferred stock, shares issued					40,300
Preferred stock, shares outstanding					40,300
Dividend rate, percentage		10%
Liquidation preference value (in Dollars)		$ 25
Redemption price, per share (in Dollars per share)					$ 37.5
Stated value percentage					150%
Series O Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized			2,000
Preferred stock per share (in Dollars per share)			$ 1,000
Preferred stock, shares outstanding					5
Dividend rate, percentage			8%		4%
Aggregate preferred stock, share issued					965,252
Percentage of dividing conversion price					200%
Aggregate of shares					436,819
Conversion of Stock, Shares Issued					5
Series O Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares issued					185
Preferred stock, shares outstanding					185
Series P Preferred Stocks Member
Capital Stock [Line Items]
Preferred stock, share authorized			500
Preferred stock per share (in Dollars per share)			$ 1,000
Preferred stock, shares outstanding					30
Percentage of dividing conversion into common stock			4.99%
Increased common stock percentage			9.99%
Minimum [Member] | Series O Preferred Stock [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding					4.99%
Maximum [Member] | Series O Preferred Stock [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding					9.99%

Capital Stock (Details) - Par_4

Capital Stock (Details) - Part-4 - $ / shares			6 Months Ended
	Nov. 16, 2020	Aug. 21, 2020	Jun. 30, 2024
Series Q Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized		2,000
Preferred stock per share (in Dollars per share)		$ 1,000
Dividend rate, percentage		12%
Percentage of dividing conversion into common stock		200%
Aggregate preferred stock, share issued			4,576,458
Conversion of Stock, Shares Issued			20
Preferred stock, shares issued			410
Preferred stock, shares outstanding			410
Series R Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized	5,000
Preferred stock per share (in Dollars per share)	$ 1,000
Dividend rate, percentage	10%
Percentage of dividing conversion into common stock	200%
Aggregate preferred stock, share issued			135
Preferred stock, shares issued			1,473
Preferred stock, shares outstanding			1,473
Aggregate shares of common stock			30,496,772
Minimum [Member] | Series Q Preferred Stock [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding		4.99%
Minimum [Member] | Series R Preferred Stock [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding	4.99%
Maximum [Member] | Series Q Preferred Stock [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding		9.99%
Maximum [Member] | Series R Preferred Stock [Member]
Capital Stock [Line Items]
Common stock outstanding increased percentage	9.99%

Capital Stock (Details) - Par_5

Capital Stock (Details) - Part-5 - USD ($)						6 Months Ended		12 Months Ended
	Feb. 11, 2022	May 26, 2021	Apr. 28, 2021	Feb. 05, 2021	Apr. 27, 2020	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Apr. 22, 2022	Feb. 18, 2022	Dec. 06, 2021	Mar. 01, 2021
Capital Stock [Line Items]
Preferred stock, share authorized						600,000,000		600,000,000
Preferred stock per share (in Dollars per share)						$ 0.0001		$ 0.0001
Conversion price decrease (in Dollars per share)							$ 0.0064
Fair value of warrants (in Dollars)						$ 6,593,511	$ (2,825,879)
Dividend rate, percentage					4%
Aggregate stock redeemed							589,253,845
Recognized gain on common stock (in Dollars)						1,255,178	$ 5,403,828
Fair value conversion agreements (in Dollars)						12,221
Vesting fair value (in Dollars)						$ 169,596
Conversion of shares							478,402,031
Conversion value issued (in Dollars)							$ 167,365
Market price of per share (in Dollars per share)						$ 0.0001	$ 0.01	$ 0.0001
Conversion prices (in Dollars per share)							$ 0.00816
Shares of common stock							45,217,435
Common stock services at fair value (in Dollars)						$ 412,154	$ 424,926
Shares issued for altertive vesting (in Dollars)							1,158
Common stock issued as settlement (in Dollars)						$ 12,221	26,518
Company owns share outstanding, percentage						90.83%
Convertible Notes Payable [Member]
Capital Stock [Line Items]
Principal amount (in Dollars)							91,000
Accrued interest (in Dollars)							$ 76,365
Water On Demand, Inc. (‘WODI’) Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized									50,000,000
Preferred stock per share (in Dollars per share)									$ 0
WODI [Member]
Capital Stock [Line Items]
Non-controlling interest						9.17%
Minimum [Member]
Capital Stock [Line Items]
Preferred stock per value (in Dollars per share)						$ 0.0065	$ 0.0135
Maximum [Member]
Capital Stock [Line Items]
Preferred stock per value (in Dollars per share)						$ 0.012	$ 0.0051
Common Stock [Member]
Capital Stock [Line Items]
Issuance of common stock						20,937,829	18,645,028
Conversion of shares							55,788,402
Conversion value issued (in Dollars)							$ 5,579
Shares of common stock						45,411,996	45,217,435
Common stock for alternate vesting						20,937,829	11,584,932
OriginClear, Inc. [Member]
Capital Stock [Line Items]
Issuance of common stock						45,411,996
WODI [Member]
Capital Stock [Line Items]
Preferred stock per value (in Dollars per share)						$ 0.01
Financing Agreement [Member]
Capital Stock [Line Items]
Fair value conversion agreements (in Dollars)						$ 412,154
Convertible Notes Payable [Member]
Capital Stock [Line Items]
Total aggregate proceeds (in Dollars)							$ 130,584
Shares of common stock							55,788,402
Total aggregate amount (in Dollars)						$ 2,042,500	$ 167,365
Stock price per share (in Dollars per share)							$ 0.0085
Series S Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized				430
Preferred stock per share (in Dollars per share)				$ 1,000
Dividend rate				12%
Convertible common stock percentage				200%
Conversion of Stock, Shares Issued						2,272,728
Aggregate preferred stock, share issued						10
Preferred stock, shares issued						110
Preferred stock, shares outstanding						110
Conversion value issued (in Dollars)						$ 10,000	$ 50,000
Series S Preferred Stock [Member] | Minimum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding				4.99%
Series S Preferred Stock [Member] | Maximum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding				9.99%
Series S Preferred Stock [Member] | Common Stock [Member]
Capital Stock [Line Items]
Conversion of shares						2,272,728	8,864,250
Conversion value issued (in Dollars)						$ 227	$ 886
Series U preferred stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized		5,000
Preferred stock per share (in Dollars per share)		$ 1,000
Convertible common stock percentage		150%
Preferred stock, shares outstanding						270
Conversion price decrease (in Dollars per share)		$ 0.2
Warrants outstanding						1,511,500
Fair value of warrants (in Dollars)						$ 0
Exercise prices per share (in Dollars per share)						$ 1
Conversion value issued (in Dollars)							$ 65,000
Series U preferred stock [Member] | Minimum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding		4.99%
Series U preferred stock [Member] | Maximum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding		9.99%
Series U preferred stock [Member] | Common Stock [Member]
Capital Stock [Line Items]
Convertible common stock percentage		200%
Conversion of shares							9,078,212
Conversion value issued (in Dollars)							$ 908
Series W Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized			3,390
Preferred stock per share (in Dollars per share)			$ 1,000
Convertible common stock percentage			200%
Conversion of Stock, Shares Issued						41,715,134
Aggregate preferred stock, share issued						200
Preferred stock, shares issued						696.5
Preferred stock, shares outstanding						696.5
Dividend rate, percentage			12%
Outstanding common stock percentage			4.99%
Conversion value issued (in Dollars)						$ 200,000
Series W Preferred Stock [Member] | Common Stock [Member]
Capital Stock [Line Items]
Conversion of shares						41,715,134
Conversion value issued (in Dollars)						$ 4,172
Series Y Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized											3,000
Preferred stock per share (in Dollars per share)											$ 100,000
Conversion of Stock, Shares Issued						83,840,346
Aggregate preferred stock, share issued						4.4
Preferred stock, shares issued						25.95
Preferred stock, shares outstanding						25.95
Warrants outstanding						55,614,616
Fair value of warrants (in Dollars)						$ 199,084
Subsidiary’s annual net profits percentage						25%					25%
Issuance of shares (in Dollars)						$ 575,100
Warrants issued						55,614,616
Amount of accrued dividends (in Dollars)						$ 613,215
Conversion value issued (in Dollars)						$ 440,000	$ 1,330,000
Series Y Preferred Stock [Member] | Minimum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding											4.99%
Exercise prices per share (in Dollars per share)						$ 0.13
Series Y Preferred Stock [Member] | Maximum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding											9.99%
Exercise prices per share (in Dollars per share)						$ 0.25
Series Y Preferred Stock [Member] | Common Stock [Member]
Capital Stock [Line Items]
Conversion of shares						83,840,346	233,043,093
Conversion value issued (in Dollars)						$ 8,384	$ 23,305
Series Z Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized	25
Preferred stock per share (in Dollars per share)	$ 10,000
Percentage of common stock outstanding	4.99%
Conversion of Stock, Shares Issued								25
Preferred stock, shares issued										25
Warrants outstanding						2,500,000
Fair value of warrants (in Dollars)						$ 7,730
Exercise prices per share (in Dollars per share)						$ 0.1
Warrants issued										2,500,000
Increased common stock percentage	9.99%
Conversion value issued (in Dollars)							$ 250,000
Series Z Preferred Stock [Member] | Common Stock [Member]
Capital Stock [Line Items]
Conversion of shares							61,728,395
Conversion value issued (in Dollars)							$ 6,173
Series Z Preferred Stock [Member] | WODI [Member]
Capital Stock [Line Items]
Aggregate stock redeemed						139,560,037
Series B Preferred Stock [Member] | OriginClear, Inc Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares issued						0		0
Preferred stock, shares outstanding						0		0
Series O Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, share authorized					2,000
Preferred stock per share (in Dollars per share)					$ 1,000
Conversion of Stock, Shares Issued						5
Aggregate preferred stock, share issued						965,252
Preferred stock, shares outstanding						5
Dividend rate, percentage					8%	4%
Issuance of common stock						436,819	498,280
Series O Preferred Stock [Member] | Minimum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding						4.99%
Series O Preferred Stock [Member] | Maximum [Member]
Capital Stock [Line Items]
Percentage of common stock outstanding						9.99%
Common Stock [Member]
Capital Stock [Line Items]
Aggregate stock redeemed						139,560,037
Recognized gain on common stock (in Dollars)						$ 1,255,178
Issuance of common stock						122,213,744
Market price of per share (in Dollars per share)						$ 0.01						$ 0.05
Common Stock [Member] | Conversion Agreement [Member]
Capital Stock [Line Items]
Issuance of common stock							265,181,982
Conversion Preferred Stock [Member]
Capital Stock [Line Items]
Conversion of shares						163,866,690
Conversion value issued (in Dollars)						$ 810,000	$ 2,510,000

Capital Stock (Details) - Sched

Capital Stock (Details) - Schedule of Non-controlling Interest	Jun. 30, 2024
OriginClear, Inc. [Member]
Schedule of Non-controlling Interest [Line Items]
Total ownership percentage	90.83%
Prior Reg A Holders [Member]
Schedule of Non-controlling Interest [Line Items]
Total ownership percentage	0.19%
Prior Series A Holders [Member]
Schedule of Non-controlling Interest [Line Items]
Total ownership percentage	3.87%
Prior Series B Holders [Member]
Schedule of Non-controlling Interest [Line Items]
Total ownership percentage	5.11%
WODI common stock holders [Member]
Schedule of Non-controlling Interest [Line Items]
Total ownership percentage	100%

Restricted Stock Grants and W_3

Restricted Stock Grants and Warrants (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Options and Warrants [Line Items]
RSGAs exceeds amount	$ 412,154	$ 424,926
Aggregate shares issued (in Shares)	20,937,829
Stock-based compensation	$ 169,599
Proceeds of warrants	426,230
Derivative liability	14,336,270		$ 7,742,759
Restricted Stock Grant Agreements [Member]
Options and Warrants [Line Items]
RSGAs exceeds amount	1,500,000
Restricted Stock Grant Agreements [Member] | Chief Executive Officer [Member]
Options and Warrants [Line Items]
RSGAs exceeds amount	$ 15,000,000
Warrant [Member]
Options and Warrants [Line Items]
Issued warrants for proceeds (in Shares)	1,427,049
Proceeds of warrants	$ 426,230
Purchase of warrants (in Shares)	2,020,000
Exercise price (in Dollars per share)	$ 1
Warrant term	3 years
Derivative liability	$ 234,791
Warrants outstanding	$ 0

Restricted Stock Grants and W_4

Restricted Stock Grants and Warrants (Details) - Schedule of Warrant Activity	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Schedule of Warrant Activity [Line Items]
Number of Warrants, Outstanding - beginning of period | shares	64,401,089
Weighted average exercise price, Outstanding - beginning of period | $ / shares	$ 0.1383
Number of Warrants, Granted | shares	4,600,800
Weighted average exercise price, Granted | $ / shares	$ 0.125
Number of Warrants, Exercised | shares
Weighted average exercise price, Exercised | $ / shares
Number of Warrants, Expired | shares	(48,500)
Weighted average exercise price, Expired | $ / shares	$ 1
Number of Warrants, Outstanding - end of period | shares	68,953,389
Weighted average exercise price, Outstanding - end of period | $ / shares	$ 0.1368

Restricted Stock Grants and W_5

Restricted Stock Grants and Warrants (Details) - Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	68,953,389
Warrants Exercisable (in Dollars per share) | $ / shares	$ 68,953,389
0.0200 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	600,000
Warrants Exercisable (in Dollars per share) | $ / shares	$ 600,000
0.1000 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	2,500,000
Warrants Exercisable (in Dollars per share) | $ / shares	$ 2,500,000
0.2500 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	3,760,000
Warrants Exercisable (in Dollars per share) | $ / shares	$ 3,760,000
0.0275 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	8,727,273
Warrants Exercisable (in Dollars per share) | $ / shares	$ 8,727,273
0.1250 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	51,854,616
Warrants Exercisable (in Dollars per share) | $ / shares	$ 51,854,616
1.0000 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding | shares	1,511,500
Warrants Exercisable (in Dollars per share) | $ / shares	$ 1,511,500
Minimum [Member] | 0.0200 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 2 months 1 day
Minimum [Member] | 0.1000 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	6 years 10 months 28 days
Minimum [Member] | 0.2500 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 7 months 20 days
Minimum [Member] | 0.0275 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	3 years 2 months 12 days
Minimum [Member] | 0.1250 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 5 months 19 days
Minimum [Member] | 1.0000 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 months 23 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)			6 Months Ended
	Jan. 25, 2021	Nov. 19, 2020	Jun. 30, 2024	Jun. 30, 2023	Aug. 31, 2015
Convertible Promissory Notes [Line Items]
Aggregate remaining balance			$ 2,019,747
Conversion price per share (in Dollars per share)				$ 0.00816
Conversion prices				$ 100,000
Conversion price per share (in Dollars per share)				$ 0.0064
Derivative liability			$ 14,101,479
2014-2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Interest rate			10%
Trade price percentage			50%
OID Notes [Member]
Convertible Promissory Notes [Line Items]
Trade price percentage			50%
Aggregate remaining amount			$ 184,124
Accrued interest			$ 13,334
Maturity date			Jun. 30, 2023
Conversion price			$ 30,620
Conversion price per share (in Dollars per share)			$ 5,600
Aggregate of shares			$ 139,560,037
2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Interest rate					10%
Trade price percentage			50%
Dec 2015 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate			0%
Sep 2016 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate			0%
Accounts payable			$ 430,896
Nov 2020 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate		10%
Trade price percentage		50%
Conversion price per share (in Dollars per share)		$ 0.05
Penalty per day		$ 2,000
Jan 2021 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate	10%
Trade price percentage	50%
Conversion price per share (in Dollars per share)	$ 0.05
Penalty per day	$ 2,000
Convertible Secured Promissory Notes [Member]
Convertible Promissory Notes [Line Items]
Convertible secured promissory notes			20,068,589
Unsecured Convertible Promissory Notes [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining balance			683,700
Unsecured Convertible Promissory Notes [Member] | OID Notes [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining balance			62,275
Unsecured Convertible Promissory Notes [Member] | 2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining balance			1,200,000
Unsecured Convertible Promissory Notes [Member] | Nov 2020 Note [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining balance			13,772
Unsecured Convertible Promissory Notes [Member] | Jan 2021 Note [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining balance			60,000
Dec 2015 Note [Member]
Convertible Promissory Notes [Line Items]
Accounts payable			$ 432,048
Minimum [Member]
Convertible Promissory Notes [Line Items]
Conversion price (in Dollars per share)			$ 4,200
Minimum [Member] | 2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Conversion prices			$ 1,400
Maximum [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Conversion price (in Dollars per share)			$ 9,800
Maximum [Member] | 2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Conversion prices			$ 5,600
Convertible Notes Payable [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes [Line Items]
Percentage of average of lowest sale prices			75%
Convertible Notes Payable [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes [Line Items]
Percentage of average of lowest sale prices			75%
Convertible Notes Payable [Member] | Nov 2020 Note [Member]
Convertible Promissory Notes [Line Items]
Convertible debt		$ 50,000
Convertible Notes Payable [Member] | Jan 2021 Note [Member]
Convertible Promissory Notes [Line Items]
Convertible debt	$ 60,000
Convertible Notes Payable [Member]
Convertible Promissory Notes [Line Items]
Interest rate			10%
Convertible debt			$ 2,042,500	$ 167,365
Convertible Notes Payable [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes [Line Items]
Remaining balance			167,048
Convertible Notes Payable [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes [Line Items]
Remaining balance			430,896
Common Stock [Member]
Convertible Promissory Notes [Line Items]
Aggregate amount			$ 1,297,000

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of Outstanding Convertible Promissory Notes - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Outstanding Convertible Promissory Notes [Abstract]
Convertible promissory notes	$ 2,617,691
Less current portion	597,944	$ 2,472,944
Total long-term liabilities	$ 2,019,747

Convertible Promissory Notes _3

Convertible Promissory Notes (Details) - Schedule of Maturities of Long-Term Debt	Jun. 30, 2024 USD ($)
Schedule of Maturities of Long-Term Debt [Abstract]
2024 (remaining 6 months)
2025	82,472
2026	1,875,000
2027
2028	62,275
Total	$ 2,019,747

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Revenue from Contracts with Customers [Line Items]
Contract asset	$ 476,906	$ 445,102
Contract liability	1,619,759	$ 1,346,366
Continuing Operations [Member]
Revenue from Contracts with Customers [Line Items]
Aggregate revenue	6,573		$ 13,146
Discontinued Operations [Member]
Revenue from Contracts with Customers [Line Items]
Aggregate revenue	$ 2,604,196		$ 3,823,932

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of Good or Service from Contracts with Customers - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	$ 2,610,769	$ 3,837,078
Equipment Contracts [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	1,167,482	1,980,345
Component Sales [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	715,977	378,872
Pump Stations [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	487,791	305,712
Waste Water Treatment Systems [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	134,262	1,124,075
Services Sales [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	72,184	33,015
Commission & Training [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	26,500	1,913
Rental Income [Member]
Schedule of Good or Service from Contracts with Customers [Line Items]
Revenue	$ 6,573	$ 13,146

Financial Assets (Details)

Financial Assets (Details) - USD ($)			6 Months Ended
	Nov. 12, 2021	May 15, 2018	Jun. 30, 2024	Jun. 30, 2023
Financial Assets [Line Items]
Stock issued				$ 1,158
Preferred shares fair value			3,200
Aggregate share issued				45,217,435
Investment in securities in fair value amount			$ 36,167
OriginClear, Inc. technology [Member]
Financial Assets [Line Items]
Fair value market price per share		$ 0.0075
Series C Convertible Preferred Stock [Member]
Financial Assets [Line Items]
Stock issued		$ 30,000
Series C Convertible Preferred Stock [Member] | OriginClear, Inc. technology [Member]
Financial Assets [Line Items]
Shares received		4,000
WTII common stock [Member]
Financial Assets [Line Items]
Aggregate share issued	45,208,649
WTII common stock [Member] | Series C Convertible Preferred Stock [Member]
Financial Assets [Line Items]
Shares received		1,000,000

Loans Payable (Details)

Loans Payable (Details) - USD ($)			6 Months Ended
	May 13, 2024	Jun. 12, 2020	Jun. 30, 2024	Jun. 30, 2023	Dec. 06, 2023
Loans Payable [Line Items]
Assets amount			$ 1,749,970
Finance cost			624,810
Net balance			0
Loan			0
Gain on write-off payable			(30,646)
Grant loan amount	$ 150,000
Remaining balance			145,890
Percentage of future receivables	11%
Receivables amount	$ 225,000		33,000	169,572
Agreement fee	$ 15,000
Outstanding arrangement amount			145,250
Recognized as debt discount			75,000
Recognized as interest expense			$ 90,000
Secured Debt [Member]
Loans Payable [Line Items]
Assets amount					$ 149,900
Finance cost					59,900
Net amount					$ 90,000
Notes Payable, Other Payables [Member]
Loans Payable [Line Items]
Grant loan amount		$ 150,000

WODI (Details)

WODI (Details)

1 Months Ended

6 Months Ended

12 Months Ended

Oct. 25, 2023 shares

Sep. 21, 2023 shares

Dec. 22, 2022 USD ($) shares

Nov. 16, 2022 USD ($) shares

Jul. 31, 2021 USD ($)

Jun. 30, 2024 USD ($) shares

Jun. 30, 2023 USD ($) $ / shares shares

Dec. 31, 2022 USD ($)

Dec. 31, 2021 USD ($)

Dec. 31, 2023 shares

Apr. 14, 2023 shares

Apr. 10, 2023 shares

Feb. 07, 2023 USD ($) $ / shares

Nov. 04, 2022 USD ($)

Mar. 01, 2021 $ / shares

Water on Demand Inc. (‘WODI’) [Line Items]

Total purchase of membership interest (in Dollars) | $

$ 169,599

$ 120,540

Note payable to related party (in Dollars) | $

$ 737,267

Public share price (in Dollars per share) | $ / shares

$ 0.1

$ 0.05

Maximum sufficient votes percentage

65%

Other assets exchange shares

6,000,000

Common stock, shares Issued

1,613,089,087

1,399,782,046

Common stock, shares outstanding

1,613,089,087

1,399,782,046

Aggregate note payable (in Dollars) | $

$ 1,327

$ 1,273

Aggregate impaired expenses (in Dollars) | $

$ 116,000

$ 114,000

$ 116,000

Restricted shares percentage

25%

Converted shares

478,402,031

WODI [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Aggregate sale of stock issued

2,171,068

Merger Plan Agreement [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Conversion ratio

0.19737

Share-Based Payment Arrangement, Tranche One [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Vested shares percentage

6.25%

Share-Based Payment Arrangement, Tranche Two [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Vested shares percentage

6.25%

Series of Individually Immaterial Business Acquisitions [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Business combination percentage

75%

Busines combination stock price (in Dollars per share) | $ / shares

$ 50,000

Sponsor [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Membership interest, percentage

100%

Sale of stock shares

2,343,750

Related Party [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Note payable to related party (in Dollars) | $

$ 737,267

WODI [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Investments amount (in Dollars) | $

$ 1,000

Aggregate sale of stock issued

12,000

Total proceeds (in Dollars) | $

$ 60,000

Common stock, shares Issued

10,000,000

Common stock, shares outstanding

10,000,000

Aggregate note payable (in Dollars) | $

$ 5,051,985

Unsecured promissory notes (in Dollars) | $

$ 5,051,985

Aggregate impaired expenses (in Dollars) | $

$ 1,128,000

Restricted shares percentage

25%

Common stock outstanding percentage

1%

WODI [Member] | Convertible Secured Promissory Notes [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Merger percentage

10%

Fortune Rise Sponsor, LLC [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Payment for purchase (in Dollars) | $

$ 1,137,267

Total purchase of membership interest (in Dollars) | $

$ 400,000

Business combination of additional term

1 year

Water on Demand, Inc [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Deposit amount (in Dollars) | $

$ 977,500

WODI RSGAs [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Issuance of stock

15,550,000

2,581,344

Converted shares

3,069,100

Class B Common Stock [Member] | Fortune Rise Sponsor, LLC [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Stock issued

5,687,847

2,443,750

10,514,410

Stock outstanding

5,687,847

2,443,750

10,514,410

Total purchase of membership interest (in Dollars) | $

$ 400,000

Class A Common Stock [Member] | Fortune Rise Sponsor, LLC [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Stock issued

5,687,847

10,514,410

Stock outstanding

5,687,847

10,514,410

Class B Founder Shares [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Other asset held-for-sale (in Dollars) | $

$ 400,000

WODI Common Stock [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Issuance of stock

15,550,000

Common Stock [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Issuance of stock

122,213,744

Common stock outstanding percentage

1%

Line of Credit (Details)

Line of Credit (Details) - Line of Credit [Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Line of Credit [Line Items]
Aggregate amount		$ 345,875
Interest rate, percentage		26.07%
Paid principal	$ 292,812
Leaving a principal balance	$ 53,063

Assets Held for Sale _ Contin_2

Assets Held for Sale – Continuing Operations (Details) - USD ($)					1 Months Ended	12 Months Ended
	Jun. 21, 2023	Apr. 08, 2023	Jan. 31, 2023	Mar. 01, 2021	Jul. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2024	May 13, 2024	Jun. 30, 2023	Feb. 07, 2023
Assets Held for Sale – Continuing Operations [Line Items]
Warrants acquire (in Shares)				25,200,000
Price per share (in Dollars per share)				$ 0.05							$ 0.1
Asset for sale					$ 630,000	$ 514,000
Impairment					116,000	114,000	$ 116,000
Offer price						400,000
Property plant And equipment						114,000
Sale of the property			$ 400,000
Initial payment		$ 235,000
Remaining initial payment		$ 165,000
Installments			$ 11,000
Payment received	$ 164,935
Closing fees	65,493
Receivable	$ 169,572
Receivable amount								$ 33,000	$ 225,000	$ 169,572
Maximum [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Asset for sale							630,000
Minimum [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Asset for sale					$ 514,000	400,000	$ 514,000
Buenos Aires [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Impairment						114,000
Buenos Aires [Member] | Maximum [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Asset for sale						514,000
Buenos Aires [Member] | Minimum [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Asset for sale						$ 400,000
Series T Preferred Stock [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Number of share issued (in Shares)				630
Aggregate value				$ 630,000
Series T Preferred Stock [Member] | Series T [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Number of share issued (in Shares)				630
Series T Preferred Stock [Member] | Buenos Aires [Member]
Assets Held for Sale – Continuing Operations [Line Items]
Number of share issued (in Shares)				630
Aggregate value				$ 630,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	Jun. 30, 2024 USD ($) ft²
Commitments and Contingencies [Line Items]
Area of land (in Square Feet) | ft²	12,000
Monthly rent	$ 8,500
Warrant reserve	$ 20,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]	1 Months Ended
	Aug. 12, 2024 USD ($) shares	Aug. 07, 2024 shares	Aug. 01, 2024 $ / shares shares	Jul. 30, 2024 shares
Subsequent Events [Line Items]
Conversion shares		52,271,686		5,788,449
Investor [Member]
Subsequent Events [Line Items]
Number of warrant issued	2,600,000
OCLN Preferred Stock Conversions [Member]
Subsequent Events [Line Items]
Converted series			0.82
Conversion shares			18,927,182
Minimum [Member] | OCLN Preferred Stock Conversions [Member]
Subsequent Events [Line Items]
Conversion price per share (in Dollars per share) | $ / shares			$ 0.0068
Maximum [Member] | OCLN Preferred Stock Conversions [Member]
Subsequent Events [Line Items]
Conversion price per share (in Dollars per share) | $ / shares			$ 0.0071
Series Y Preferred Stock [Member]
Subsequent Events [Line Items]
Aggregate sale of stock issued	3.25
Purchase price of share (in Dollars) | $	$ 325,000